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ABSTRACT 
 
 
 
The SAGA family of co-activators play a major role in regulating eukaryotic gene 
expression. These multiprotein complexes are highly conserved across all eukaryotic 
species, from budding yeast to humans. Transcription of inducible genes is facilitated by 
SAGA, a multi-protein complex, which mediates acetylation of ε-amino tails of the 
histone H3. The acetyltransferase activity of SAGA is harbored in the Gcn5 subunit of 
the complex. Previous studies characterized the enzymatic properties of the 
recombinantly expressed HAT domain of Gcn5 from Saccharomyces cerevisiae on 
synthetic H3 peptides. We were interested in studying the properties of endogenous 
Gcn5, in the context of full SAGA complex. We also utilized nucleosomes as substrates, 
since the basic structural unit of chromatin is a nucleosome. 
Towards this end, we first turned our efforts into developing a reliable, 
reproducible and sensitive assay for detecting acetylation on nucleosomes. Previous 
studies utilized filter binding assays, which work great for short peptides. Since these 
peptides are positively charged, they bind to the filter in an efficient and reproducible 
manner. Nucleosomes, being net negatively charged and structurally fragile, required an 
alternative approach. We developed bead based strategies which immobilize the 
nucleosome substrates, and thus circumvented the above-mentioned issues. 
We utilized a trinucleosome system to study the pattern of acetylation established 
across the nucleosomal array under exhaustive and initial-rate conditions. We  observed a 
2 fold preference for nucleosomes harboring longer linker lengths on one side. By further  
optimizing the bead based assay for performing initial rate, steady state kinetics, we  
 
x 
 
designed several nucleosomes harboring different lengths of linkers on both sides. Our data 
suggest that linker DNA longer than 80 bp on one end stimulate the HAT activity of SAGA. 
We also show that a long linker in combination with linker on the other side of the 
nucleosome stimulates SAGA to the maximum potential. 
Steady state data on different nucleosomes revealed that SAGA binds to all 
substrates pretty tightly, but the turnover rates were lower than expected. Our bead based 
assay also allowed us to perform single turnover experiments, which give important 
information on the nature of chemical step. Preliminary data suggests that indeed, the first 
turnover is pretty fast, but subsequent cycles are much slower. This indicates a step post 
catalysis, such as product release, is limiting. We are currently working towards 
understanding this burst phase in more detail. 
In vivo, different factors work in concert to regulate gene transcription. For 
example, DNA bound activators recruit SAGA to target genes to initiate transcription. 
Previous studies have followed a combination of genetic and biochemical approaches to 
qualitatively assess this interaction. In order to investigate the effect of this interaction from 
a quantitative perspective, we incorporated an activator binding site in the linker DNA of 
one of the nucleosomes. Our preliminary data suggests that activator modulates SAGA 
complex in potentially two different ways, even beyond the stimulation mediated by linker 
DNA. This might explain how the cell is able to quickly respond to stress environments and 
turn on genes to achieve homeostasis. 
Overall, our results help us in gaining better insights into the mechanisms 
employed by the SAGA complex in maintaining basal levels of acetylation under normal 
x 
 
conditions, and establishing hyperacetylated domains under inducing conditions. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
Chromatin 
 
The discovery of DNA as the genetic material all living organisms remains one of the 
most crucial discoveries in understanding the fundamentals of all living things. Realizing 
genes are short segments of DNA which contribute to inheritable transmittance of 
characteristics led to the golden decade in the history of science. However, contrary to a 
long-standing belief, our genetic material is more than just naked DNA floating freely in 
the nucleus. Long stretches of DNA, often meters in length, need to be efficiently 
packaged within microns of a cell nucleus. This dilemma is addressed by packaging the 
DNA into a highly condensed form, by wrapping it around proteins, to form a nucleo-
protein complex known as chromatin, which in its most extended state resembles beads 
on a string.  
 
Nucleosomes: The basic structural unit of chromatin 
            
The characteristics of the basic structural unit of chromatin, the nucleosome, have 
been investigated in detail. Pivotal studies conducted by Luger and co-workers shed light 
on the bead-like structure of nucleosomes. A nucleosome consists of 147 bp of DNA 
wrapped roughly 1.65 times around a spool of proteins known as histones, in a left 
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handed superhelical fashion [1; 2] . Two copies each of histone H2A, H2B, H3 and H4 
constitute an octamer, and sequester genomic DNA. Histones are highly positively 
charged and thus interact quite strongly with the negatively charged DNA. The N-
terminal tails of histones are highly unstructured, and protrude out from the core structure 
and beyond the DNA. 
All histone proteins are highly conserved across all eukaryotic species and 
deletion mutants are lethal. Even though DNA sequences govern the stability of resultant 
nucleosomes, variations in DNA and histone sequences are generally readily 
accommodated [3]. This is necessary to be able to assemble nucleosomes across a wide 
variety of types of sequences within genomes. However, some DNA sequences are better 
suited to be wrapped around nucleosomes, and this sequence preference likely contributes 
at least partially to the positioning of nucleosomes throughout the genome.   
In the genome, nucleosomes are linked to each other by short stretches of naked 
DNA, known as linker DNA. The lengths of these stretches vary largely across the 
genome. Transcriptionally silent loci tend to have regularly spaced nucleosomes, whereas 
more active loci have irregularly phased nucleosomes packing density, which results in 
variable lengths of accessible linker DNA. The linker DNA often harbors transcription 
factor and other modifying complex binding sites, and is often utilized as a means to 
regulate transcription and other cellular processes.  
All eukaryotic genomes are studded with nucleosomes, the frequency of which 
varies from organism to organism. For example, in budding yeast, a nucleosome can be 
found every 200 bp ± 40 bp. Thus, a significant proportion of the eukaryotic genome is 
wrapped around histone proteins, and this has important ramifications for cellular 
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processes that utilize DNA as a substrate, such as DNA replication, repair and 
transcription. Because DNA wrapped around nucleosomes is less accessible to other 
proteins, chromatin is largely repressive in nature. Yet, the cell is able to faithfully 
replicate and segregate the genetic information to the daughter cells, and is able to 
respond and adapt quickly to changes in the environment to access genomic DNA for 
transcription. The cell uses a number of different mechanisms to change the structural 
properties of nucleosomes. Histone variants that are either more or less stable than the 
canonical histones can be incorporated [4; 5]. For example, CENP-A which is a variant of 
H3, is found exclusively in the centromeric regions of the genome [6]. H2A.Z, on the 
other hand, is often present in the promoter regions of actively transcribing genes [7; 8]. 
Additionally, the position and stability of nucleosomes can be directly changed by ATP-
dependent remodeling complexes, such as SWI-SNF and ISWI family of remodelers [9; 
10; 11]. The properties of nucleosomes are regulated by the cells by addition of post-
translational modifications to the histone proteins [12]. Thus, there are mechanisms 
existing in the cell to overcome this repressive nature when required, and mechanisms to 
return chromatin back to the original state afterwards.  
 
Histone code hypothesis – the tails tell a tale 
 
Studies performed in the 1960s by Allfrey’s group correlating nucleosome 
acetylation with gene activation brought a paradigm shift in the field of chromatin 
biology [13]. Subsequent studies showed that histones are heavily modified with a 
multitude of post translational modifications. A majority of these modifications occur on 
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the tails, with some in the globular region. As mentioned earlier, the tails protrude out of 
the nucleosome, and thus provide a surface for potential interactions. The tails are also 
involved in mediating histone-DNA and histone-histone contacts and modifications of the 
residues have important consequences for the structure and stability of the nucleosome 
[12; 14].  
A multitude of modifications have been detected on the histone tails. Initial 
attention was brought to this aspect when it was discovered that a lot of complexes that 
are usually tethered to the chromatin had modifying activities. Proteomic approaches, 
such as mass spectrometry analysis of histones, rapidly led to accumulation of a 
staggering amount of data, all converging to the fact that histone tails serve as a crucial 
target of various modification enzymes [12; 15]. Figure 2 lists the possible modifications 
that have been detected till date. As the figure shows, the same residue can be marked 
with different modifications, and also a small stretch can harbor multiple marks [16]. 
Chromatin is a highly dynamic structure with respect to these marks. Not all of 
them are present at the same time, and the landscape rapidly and continually evolves with 
different upstream signals. This led to the genesis of the histone code hypothesis, which 
states that the downstream cellular effect is a result of combined effects of the various 
modifications present at and surrounding the target loci. Since all of these modifications 
are reversible, and are deposited or erased rapidly, there is no one code, but a language, 
where each mark is a letter that makes sense in the context of all the other marks 
constituting the word [12; 15; 17].  
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Acetylation 
Of the several modifications mentioned above, lysine acetylation has been most 
extensively studied, and it’s effects well established. The ε-amino group of the side chain 
of lysine is a target of various modifying enzymes. Transfer of the acetyl group to the 
positively charged lysines neutralizes the charge, and thus weakens the interactions 
between the modified histone and DNA. This leads to a number of structural changes. For 
example, the stability of the nucleosome is changed in some cases, whereas in others, it 
imparts different mobility to the octamer. More extensively, it is a mechanism to open the 
chromatin structure to a more de-condensed state. Indeed, Shogren-Knaak and coworkers 
have shown that acetylation of lysine 4 on H4 results in a less compacted nucleosomal 
array [18]. This has important consequences for mediating transcriptional control. One 
can imagine that unraveling of the chromatin into a more open structure will help in 
facilitating transcription. This has been supported over the years, since histone 
acetylation is largely correlated with transcriptionally active chromatin. Lysine 
acetylation can also affect transcription through a mechanism separate from directly 
changing chromatin structure and stability. Histone acetylation creates new platforms for 
tethering of chromatin modifying complexes. Effector proteins that harbor acetylation 
recognition domains get recruited on specific sites, and thus mediate downstream effects. 
It can also inhibit recruitment of other classes of enzymes, by destroying the un-
acetylated sites. This prevents deposition of repressive marks, thereby inhibiting 
transcriptional repression and/or chromatin compaction.  
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Spt-Ada-Gcn5-Acetyltransferase (SAGA) – The HAT on the chromatin 
The enzymes that mediate acetylation on chromatin are referred to as histone 
acetyltransferases (HATs). The first link between histone acetylation and gene regulation 
came from the discovery that budding yeast protein Gcn5, which previously was known 
to be involved in gene transcription, was also shown to possess histone acetyltransferase 
activity [19; 20]. Since then, a number of other HATs have been discovered, and a 
combination of genetic, biochemical and structural studies unequivocally established the 
role of histone acetylation in regulation of chromatin structure and associated processes, 
such as transcription, DNA replication, DNA repair etc. [21; 22].  
Acetyltransferases have been divided into five different families, GNATs (Gcn5-
related-N-acetyltransferases); MYST (MOZ, Ybf2, Sas2 and Tip60) related HATs; 
p300/CREB-binding protein (CBP) HATs; general transcription factor HATs including 
TAF (TBP- associated-factor) and finally, the nuclear hormone related HATs [23; 24; 
25]. Some of the now known HATs were previously known to assist in transcription as 
adapters or co-activators, but later shown to harbor histone specific acetyl transferase 
activity. It is now known, that these HATs also have the ability to acetylate non-histone 
substrates, such as transcription factors and other chromatin modifying complexes, and 
are thus referred to as general ATs, or Lysine ATs (KATs).  
Biochemical characterization of the yeast Gcn5 protein showed that it acts 
specifically on the lysine 14 of H3, in vitro. However, researchers were left puzzled for a 
while when it failed to act on core histones and nucleosomes, as observed in vivo.  The 
purification and characterization of several Gcn5 containing endogenous complexes 
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solved this mystery. Gcn5 by itself can only target H3K14, but has an expanded 
specificity in the context of the entire complex [26; 27]. Song Tan and co-workers 
showed that additional subunits Ada2 and Ada3 are necessary and sufficient to expand 
this specificity and to also endow the ability to act on full histones, as well as chromatin 
substrates [28]. 
Further, Gcn5 is present in three different complexes in yeast. They are the 1.8 
MDa complex known as the SAGA complex, the 800 kDa complex known as the ADA 
complex, and a complex very similar to SAGA, known as SALSA/SLIK (SAGA 
altered.Spt8 absent/SAGA like). Chromatography and other biochemical approaches 
established that these three are distinct complexes, despite a large overlap of subunits 
[29]. As expected, they have redundant roles in the cell, and are able to compensate for 
each other. However, the presence of unique subunits also makes them indispensable for 
certain pathways [25].  
The SAGA complex is highly conserved across all eukaryotic species and overall 
has a very similar composition of subunits. In yeast, it is a 1.8 MDa complex, comprising 
of at least 19 different polypeptides [21; 25]. Multiprotein complexes offer several 
advantages in cellular context. By tethering different activities together, the cell is poised 
to function much more efficiently and respond quickly to any changes in the extracellular 
environment. Low resolution Electron Microscopy (EM) studies showed that the complex 
is organized into five different modules, each of which harbor a different function [30]. 
The recruitment module is involved in interactions with transcription activators and other 
factors involved in transcription. Tra1 is the main subunit of this module, and is 400 kDa 
in size. This offers several interaction opportunities and is often seen as a scaffold [31; 
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32]. The acetylation module comprises of Gcn5, Ada2, Ada3 and Sgf29. Gcn5 is the 
HAT, but needs proper interactions with Ada2 and Ada3 to be able to act on in vivo 
chromatin substrates, i.e., nucleosomes either one or multiple in tandem. The TBP 
interaction unit, which comprises mainly of Spt3 and Spt8, is directly involve in 
interacting with the TATA binding protein, and thus possess the classic co-activator 
properties. The de-ubiquitination (Dub) module comprises of Ubp8, Sus1, Sgf11 and 
Sgf73, and accounts for the second enzymatic activity of the complex [30; 33]. Ubp8 is a 
deubiquitinase and removes the ubiquitin moiety from the lysine side chain of residue 
123 on H2B, in yeast. Similar to Gcn5, Ubp8 works in the context of the Dub module and 
is a poor enzyme by itself.  More and more of such examples are being discovered, 
underscoring the importance of context in the world of chromatin. The fifth module is the 
architectural module and is crucial in maintaining the overall structural integrity of the 
complex. Spt7, Spt20, Ada1 and some general TAFs such as TAF5, 6, 9 and 12 constitute 
this module. The overall subunit composition is strikingly similar across different 
species, such as yeast, Drosophila and humans, suggesting similar functions and 
utilization of similar principles to modulate chromatin [21; 22; 34; 35].  
As shown, different subunits harbor different domains which allow them to 
mediate different activities. For instance, Gcn5 has a HAT domain which catalyzes the 
acetyltransferase reaction and a bromodomain, which recognizes acetylated lysines on the 
histone, thereby facilitating recruitment on the acetylated regions of chromatin.  
Given the fact that SAGA is conserved in all eukaryotes and harbors a multitude 
of functions, it’s not surprising to know that it is involved in a variety of cellular 
processes, not just transcription. Also, misregulations in these activities leads to 
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developmental issues and diseases. For instance, gcn5 null mice do not survive post 10.5 
days, and gcn5 null fruit flies die due to failure of metamorphosis [36; 37]. In humans, 
the Sca7 subunit can undergo polyglutamine expansion and this results in 
neurodegeneration. The mutant subunit gets incorporated into the complex and results in 
mistargeting and aberrations in the activity. Studies have shown that it directly inhibits 
the HAT activity of Gcn5 [38; 39]. Mutations in Ubp8 enzyme leads to a variety of 
cancers, and is in fact a part of 11 signature mutations that result in a wide variety of 
cancers [40; 41]. A lot of current drug targets being developed are aimed against the 
domains present in the SAGA complex, thereby giving impetus to a need for a greater 
understanding of how this complex functions to ensure the success of an organism.  
 
Promoter specific targeted acetylation 
Genome-wide transcriptional profiling of SAGA deletions in budding yeast 
indicates that SAGA regulates the transcription of about 5-10% of the total genes [42; 
43]. Most of these genes are up-regulated during stress conditions, such as glucose 
deprivation, amino-acid starvation, phosphate shortage, heat shock and ER specific 
stresses [44; 45; 46; 47]. Recent studies have also shown that Gcn5 promotes resistance 
to UV-mediated damage and helps in maintaining the overall integrity of the genome [48; 
49].  Thus, SAGA is largely involved in the regulation of stress specific pathways. This 
specificity is ensured so that the promoters of only a subset of genes undergo Gcn5 
mediated hyper-acetylation, to initiate transcription.  
GCN5 was identified during one of the genetic screens that looked for factors 
which directly interacted with Gal4VP16, a hybrid transcriptional activator that has the 
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DNA binding domain of endogenous GAL4 activator, and the activation domain of 
VP16, a viral activator protein from herpes simplex virus [50; 51]. Since then, Gcn5 and 
SAGA have been shown to physically interact with a variety of other transcription 
activators. These DNA bound proteins are highly specific for their target loci, which is 
usually the UAS region in the promoter. Once the signal arrives, these activators then 
recruit SAGA to the promoters to kick start transcription. At these target loci, SAGA can 
facilitate transcription in several different ways. For instance, Gcn5 acetylates the 
neighboring nucleosomes which establishes hyper-acetylated domains. This might lead to 
nucleosome eviction. Another way is to recruit the TATA binding protein (TBP), which 
then proceeds to establish the pre-initiation complex, thereby sending the message to 
RNA Polymerase II to begin transcribing the downstream coding region [52; 53].  
Several studies have been done to look at the profile of acetylated histones 
generated, following the targeted recruitment of SAGA. It was found, that at several loci, 
SAGA acted on 600 bp, proximal to the target site, thereby spanning 2-3 nucleosomes. 
Thus, a sharp spike in acetylation occurs, but on a very limited region. Other HATs, such 
as NuaA4 on the other hand, create broader domains of these hyper-acetylated regions 
[54]. These profiles are dependent on activator-SAGA interactions, as relocation of the 
activator target site shifts the recruitment of SAGA, in accordance to the new site, and the 
neighboring nucleosomes are now acetylated, more than the basal levels. And the 
nucleosomes that were hyper-acetylated, now return to basal levels [54]. Also, HATs that 
do not physically interact with activators, such as NuA3, function in a more untargeted 
manner.  
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Global, untargeted acetylation 
Given the fact that SAGA is involved in regulating only a subset of genes, it was 
surprising and perhaps confusing to find a large part of the yeast genome occupied by 
SAGA. The genome was found to be largely acetylated, at levels more than expected 
background levels. Gcn5 deletion resulted in drastic decrease in widespread acetylation, 
suggesting that SAGA is also involved in establishing basal levels of acetylation 
throughout the genome, which are different from the promoter targeted hyperacetylation 
domains on specific loci [55; 56]. It is speculated that non targeted acetylation maintains 
a poised state for transcription, so that the cell is able to quickly respond to any 
extracellular changes. The role of basal levels of acetylation and widespread genomic 
occupancy of SAGA is still unclear and remains an active area of research. 
 
Kinetic mechanism of yeast Gcn5 acetyltransferase 
 
Denu and coworkers have used enzymology to gain insights into the mechanism 
employed by Gcn5 acetyltransferase to acetylate histone H3. Initial studies were 
performed using calf thymus histones, and later with synthetic H3 peptides. Both were in 
good agreement, allowing researchers to use synthetic peptides as probes to study the role 
of specific modifications. Synthetic peptides offer several advantages over biologically 
isolated histones. First, synthetic peptides are homogeneous in nature, and also allow 
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researchers to modify them at desired locations, thus studying the roles and effects of that 
specific modification. 
Enzymes that utilize acetyl-CoA as a cofactor can employ two different 
mechanisms to mediate acetylation of the desired substrates. One of them involves a 
transfer of the acetyl group on the enzyme, which is in turn transferred to the substrate. 
This mechanism involves the formation of a covalent complex between the enzyme and 
acetyl CoA. The second mechanism involves the formation of a ternary complex between 
the enzyme, acetyl CoA and the substrate. A direct transfer of acetyl group occurs from 
acetyl CoA to the second substrate.  Using the first 20 residues of H3, and the HAT 
domain of Gcn5, Denu and coworkers were able to show that the Gcn5 class of 
acetyltransferases employ the latter, by forming a ternary complex with the two 
substrates. A series of elegant and detailed approaches proved that the Glutamic Acid 173 
on Gcn5 is essential for the proper functioning of the enzyme under physiological 
conditions, and acts by deprotonating the ε-amino group of the lysine side chain of the 
histone. This allows direct nucleophilic attack by acetyl CoA, to ultimately transfer the 
acetyl moiety to the histone, within the active site of the enzyme. The reaction follows an 
ordered Bi-Bi mechanism, where acetyl CoA binds first, followed by histone to the active 
site of Gcn5. A ternary complex is formed, and the acetyl group is directly transferred to 
the lysine of histone. The acetylated peptide is then released, followed by CoA [57; 58].  
The abovementioned studies were done on a histone peptide, using the HAT 
domain of Gcn5. The enzyme acts on lysine 14 of H3 in vitro, but has an expanded 
specificity towards lysine 9, 18, 23 of H3, 8 and 16 of H4 and some residues on H2B, 
when incorporated into larger, multi-subunit complexes. We have been investigating the 
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substrate specificity and kinetic mechanisms of the entire complex on more biologically 
relevant substrates, such as nucleosomes and longer arrays of nucleosomes. These will be 
discussed in Chapter 3. 
 
Dissertation Organization 
 
The dissertation has been organized into five different chapters and one Appendix 
section. Chapter 1 encompasses a general introduction about chromatin, and how 
different aspects of it are utilized by co-activators, such as SAGA, to facilitate eukaryotic 
transcription. Chapter 2 describes a published method that was developed in order to gain 
quantitative insights into chromatin acetylation by SAGA. The work has been published 
in the journal Analytical Biochemistry. Chapter 3 builds on an observation made in 
Chapter 2, that DNA flanking nucleosomes appears to regulate SAGA activity. 
Additionally, experiments to determine how activator proteins affect SAGA activity are 
described. This work is nearly completed and will be submitted for publication shortly 
after this defense. Chapter 4 discusses ongoing work and future experiments, in 
collaboration with another graduate student in the lab. Results obtained will be a part of a 
future manuscript. Chapter 5 summarizes the conclusions reached in our studies. The 
Appendix section describes another published report that was developed as a 
collaborative effort with a graduate student in the lab, during my graduate career. The 
method described in Chapter 2 was utilized in this study.  
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FIGURES 
 
 
 
  
 
 
 
 
 
Figure 1. The structure of a mononucleosome, as determined by X-ray 
crystallography. (A) The left panel shows the view down the DNA superhelix axis, 
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whereas it’s perpendicular to it, for the right panel. (B) Half of the nucleosome core 
particle, as viewed  down the DNA axis [14].  
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Figure 2. Histones are extensively enriched with post-translational modifications. 
The tails are modified more than the central core. Shown are the different residues that 
get modified in the 4 core histones in human cells. In addition to the depicted 
modifications, other kinds of modifications also occur, such as sumoylation, ADP-
ribosylation and proline isomerization. Ac, acetylation; Me, methylation; P, 
phosphorylation; Ub, ubiquitination [16]. 
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Figure 3. Molecular architecture of the SAGA complex. (A) Low resolution cryo-EM 
studies established the modular nature of SAGA [30]. (B) More recent studies using 
cross-linking approaches gave insights into a more detailed orientation of the subunits 
[35].
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Figure 4. Pleiotropic effects of SAGA on eukaryotic gene transcription. (A) The 
recruitment module of SAGA interacts with activator protein to mediate localization on 
target genes. This allows the HAT module to acetylate neighboring nucleosomes. (B) The 
TBP interaction module furthers the interactions between SAGA and the transcriptional 
machinery, to establish the PIC. (C) Upon initiation, SAGA interacts with Pol II and 
helps in elongation. The HAT module further acetylates and often evicts the nucleosomes 
from the coding region. (D) The Dub module de-ubiquitinates H2B, ultimately causing 
phosphorylation of Pol II, to extend elongation [21].  
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Abstract 
The establishment of post-translational chromatin modifications is a major mechanism 
for regulating how genomic DNA is utilized. However, current in vitro chromatin assays 
do not monitor histone modifications at individual nucleosomes. Here we describe a 
strategy, nucleosome acetylation sequencing, that allows us to read the amount of 
modification at each nucleosome. In this approach, a bead-bound trinucleosome substrate 
is enzymatically acetylated with radiolabeled acetyl CoA by the SAGA complex from S. 
cerevisiae. The product is digested by restriction enzymes that cut at unique sites between 
the nucleosomes and then counted to quantify the extent of acetylation at each 
nucleosomal site. We find that we can sensitively, specifically, and reproducibly follow 
enzyme-mediated nucleosome acetylation. Applying this strategy, when acetylation 
proceeds extensively, its distribution across nucleosomes is relatively uniform. However, 
when substrates are used that contain nucleosomes mutated at the major sites of SAGA-
mediated acetylation, or that are studied under initial rate conditions, changes in the 
acetylation distribution can be observed. Nucleosome acetylation sequencing should be 
applicable to analyzing a wide range of modifications. Additionally, because our 
trinucleosomes synthesis strategy is highly modular and efficient, it can be used to 
generate nucleosomal systems in which nucleosome composition differs across the array. 
 
Keywords: Chromatin; Acetylation; Enzymology  
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Introduction 
In eukaryotes, the utilization of genomic DNA for processes such as transcription, 
replication, or repair, is usually preceded by post-translational modification of its 
chromatin [1]. Typically, these modifications occur over multiple nucleosomes and 
include different types of modifications on distinct histone residues. For example, during 
the transcription of inducible genes, nucleosomes of promoter regions can exhibit histone 
H3K4 methylation, H3 and H4 histone tail acetylation at multiple lysines, and histone 
H3S10 phosphorylation [2-8]. These modifications can be highly dynamic and can affect 
the establishment of additional modifications. For example, H2BK123 ubiquitinantion 
precedes and is required for H3K4 methylation [9, 10]. 
  In vitro assays offer a potentially powerful tool for elucidating how chromatin 
modifications are established by controlling the composition of the reaction components 
and by providing quantitative information on reaction rates and distributions. However, 
current in vitro assays do not provide information on how histone modifications are 
established across a span of nucleosomes. On one hand, assays have been used to 
carefully define the sites and kinetics of enzymes toward histone tail peptides [11-14], but 
provide a relatively limited approximation of the physiological substrates, chromatin. 
One the other hand, biochemical methods can generate nucleosomal arrays, but 
discerning the extent of modification across different nucleosomes is difficult. 
 To remedy these problems, we have established a method, nucleosome array 
acetylation sequencing, which allows us to read-out the extent of nucleosome 
modification across a well-defined oligonucleosome substrate. The enzyme we have 
chosen to focus on for our initial studies is the Spt-Ada-Gcn5-Acetyltransferase (SAGA) 
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complex from Saccharomyces cerevisae. This multi-subunit complex, first isolated in 
budding yeast and subsequently found to be present in a wide range of eukaryotes [15], 
facilitates the transcriptional initiation of inducible genes, such as developmental genes in 
humans [16-18]. One way it accomplishes this is by acetylating histones lysines in 
chromatin, where four lysine residues in histone H3 are the major sites of acetylation [19, 
20]. Further, SAGA contains domains that recognize histone acetylation, which 
potentially helps mediate the spread of SAGA-mediated nucleosome acetylation across 
multiple nucleosomes in inducible gene promoters [21]. Studying how SAGA acetylates 
a multiple nucleosome system offers the potential to generate new insights into the 
mechanism by which histone modifications are established across a chromatin region. 
  
Materials and Methods 
 
Chemicals  
 
Buffer components were purchased from either Fisher Scientific or Sigma 
Aldrich. [H3]-Acetyl CoA with a specific activity of 16.9 Ci/mmol was purchased from 
Moravek. Restriction endonucleases, MNase, T4 DNA ligase, and Streptavidin coated 
magnetic beads were purchased from NEB. 
 
Histone octamer preparation and mononucleosome assembly 
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Recombinant wild type and tetra-alanine (K8A, K14A, K18A, K23A) mutant H3 
X. laevis histones were expressed in E. coli and purified as described previously [22]. The 
purity of the histones was assessed by SDS PAGE and quantitated using UV 
spectroscopy. Histone octamer was prepared using the four canonical histones H2A, 
H2B, H3 and H4, as described previously [23]. The 601-177-1 strong positioning DNA 
sequence was prepared, as described previously [24, 25]. Mononucleosomes were 
assembled by rapid dilution as described previously [26, 27] and analyzed by 4% native 
PAGE to assess the degree of homogeneity and saturation. We observed that the 
innermost nucleosome, nucleosome 1, could adopt two different positions, with respect to 
the DNA. 
 
SAGA expression and purification 
 
Endogenous S. cerevisiae SAGA complex containing Spt7-TAP was affinity 
purified as described previously [28]. The purified enzyme was quantitated by Western 
Blotting, using recombinant Gcn5 as a standard. The activity of the purified complex was 
tested on H3 peptide using a filter binding assay [29].  
 
Biotinylated adapter 
 
Oligonucleotides 5’-/5PCBio/ACGACGGCCAGTGAACCACGATT–3’ and 5’-
/5Phos/GTGGTTCACTGGCCGTCGT - 3’ were purchased from IDT. To form a double 
stranded adapter, the oligos were mixed, each at a final concentration of 30 µM, in 1X 
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NEB T4 DNA Ligation buffer (50 mM Tris-HCl at pH 7.5, 10 mM MgCl2, 1 mM ATP, 
and 10 mM DTT), in a final volume of 50 µl. The mixture was heat denatured at 96-98°C 
in a heating block for 10 minutes. Subsequently, the heating block was turned off and the 
temperature was allowed to cool to 33°C. The oligos were then placed at RT for 5 
minutes before transfer to ice and subsequent storage at -20°C. The annealed product, a 
19 bp double stranded adapter with a 4 nucleotide overhang on the non-biotinylated end, 
was analyzed by 20% SDS-PAGE to assess the purity. 
 
 
Synthesis of the trinucleosome on beads  
 
For a typical synthesis, 4.66 pmoles of biotinylated adapter were attached to 50 µl 
of Streptavidin coated Dynabeads slurry (4mg/ml suspension) by incubation in 1X 
binding buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl) at room temperature for 10 
minutes with occasional agitation. The beads were washed 3 times with 50 µl 1X binding 
buffer prior to adding the adapter. The adapter-bound beads were pulled to the side of the 
tube using a magnet and the supernatant was removed. 6.99 pmoles of 601-177-1 
mononucleosomes were added one at a time in a set of sequential ligations in the 
following order: mononucleosome 1, mononucleosome 2, mononucleosome 3. Each 
ligation was done in a final volume of 40 µl in 1X ligation buffer (50 mM Tris, 10 mM 
MgCl2, 1 mM ATP, 10 mM DTT; pH 7.5) and 800U of T4 DNA ligase. The ligation 
reactions were allowed to proceed at room temperature for 12-16 hours after which, 
excess unbound nucleosome was washed off.  
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This first nucleosome, referred to as nucleosome 1, has 80 bp of additional 
sequence upstream in the linker DNA as compared to nucleosomes 2 and 3, and the 
upstream end forms a BstXI restriction site upon ligating with the adapter. The linker 
DNA between ligated nucleosomes 1 and 2 contains a BglI restriction site, whereas the 
linker DNA between ligated nucleosomes 2 and 3 contains a PflMI site.  
The resultant trinucleosome was digested with BstXI, BglI or PflMI at 37°C for 5 
hours and analyzed by 4% native PAGE to assess the quality of the ligation product. The 
trinucleosome was stored, on beads, at 4°C at a final concentration of 150 nM. 
 
Acetylation sequencing of trinucleosome 
 
WT or mutant trinucleosome, at a final concentration of 75 nM of trinucleosome, 
was acetylated under saturating or sub-saturating conditions by the SAGA complex under 
standard HAT assay conditions [30]. For both saturation and sub-saturation conditions, 
the substrate was acetylated at 30°C in 1X HAT buffer (25 mM Tris-Cl pH 7.5, 50 mM 
KCl, 5% glycerol, 1 mM DTT, 1 mM PMSF, 10 mM sodium butyrate, 2.66 µM 
unlabeled, 5.33 2.66 µM radiolabeled tritiated acetyl CoA with a specific activity of 2.66 
µM/ml) at a final volume of 50 µl. For saturation conditions, acetylation was allowed to 
occur for 4 hours by 60 nM final SAGA, whereas the reaction took place for 10 minutes 
for sub-saturation conditions by 10 nM final SAGA. The beads were washed 5 times at 
RT with 50 µl 1X washing buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 
mM DTT, 0.1% Triton X-100). They were then washed an additional 11 times, with a 7 
minute incubation at 37°C between washes, for saturation conditions and an additional 7 
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times, with 37°C incubation as above, for sub-saturating conditions. After washing, the 
beads were resuspended in 50 µl 1X digestion buffer (100 mM NaCl, 50 mM Tris-HCl, 
10 mM MgCl2, 1 mM DTT, 0.1% Triton X-100). 10 µl aliquots were transferred to 4 
fresh tubes. In order to minimize handling and reduce the total time for the assay, we 
chose to count nucleosomes generated from a single round of digestion. The samples 
were either digested with PflMI (4U), BglI (4U), BstXI (4U), or mock digested at 37°C 
for 5 hours in a final volume of 20 µl. Because 10-20% of nucleosomes were not 
liberated by BstXI digestion alone, these samples were further digested with MNase (1U) 
under conditions similar to the other digestions, for 10 minutes. The supernatants were 
added directly to vials containing 9 ml of Scintiverse BD LSC cocktail (Fisher 
Scientific). All samples were counted using a Packard tri-carb 1600 TR liquid 
scintillation analyzer. Results were analyzed from 4 independent trials of each 
experiment. 
 
Testing of nucleosome stability under assay conditions 
 
Wild type trinucleosome was subjected to the assay conditions described above 
with one exception: only cold acetyl CoA was used. The trinucleosomes were then 
digested with PflMI or BglI. Following removal of the supernatant, additional digestions 
were performed on the remaining bead-bound product. The beads were resuspended in 
1X digestion buffer and digested with BstXI or mock digested in a final volume of 20 µl, 
at 37°C for 5 hours. The supernatants were then analyzed by 4% native PAGE.  
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Comparison of nucleosome acetylation on bead and in solution. 
 
DNA for mononucleosome 1 and the biotinylated adapter were ligated and 
purified. Mononucleosome was then prepared with this DNA and wild-type octamer. For 
acetylation assays, 7.5 nM SAGA was used with 55 nM mononucleosome under 
the reaction conditions described above. For the solution assay, all components were 
mixed and the reaction was allowed to proceed for eight minutes before streptavidin 
beads were added. After two minutes, the beads were washed extensively and then 
counted as above. For the bead assay, mononucleosome were first incubated with the 
streptavidin beads for two minutes. The remaining reaction components were then added 
and the reaction was allowed to proceed for 10 minutes. Beads were then washed and 
counted. It was found that two-minutes of incubation was sufficient for complete 
nucleosome binding. To determine background signal, mock reactions were performed 
without SAGA. 
 
Results  
 
To better understand how chromatin-modifying enzymes establish histone 
acetylation across a chromatin substrate, we developed an on-bead acetylation 
sequencing assay (Fig. 1). In this strategy, a standard histone acetyltransferase assay is 
performed on a trinucleosome substrate that is attached to streptavidin coated magnetic 
beads, where the SAGA complex is the enzyme and radiolabeled acetyl CoA is the acetyl 
  
34 
donor. After removing unincorporated acetyl CoA, the acetylated trinucleosome is 
digested with different restriction endonucleases to liberate specific nucleosomes. The 
amount of radioactivity is quantified by liquid scintillation counting, allowing us to 
ultimately measure the extent of acetylation for each nucleosome.  
 
Synthesis of cleavable trinucleosome substrate  
 
As a first step, we needed to generate a bead-bound trinucleosome substrate with 
unique restriction sites between each nucleosome (Fig. 1). In previous work [26], we had 
generated short nucleosomal arrays by ligating mononucleosomes with different non-
palindromic overhangs together in solution. While this strategy was effective, it was 
difficult to separate ligated products that were incomplete from the desired array. As an 
alternative, we investigated a solid-phase nucleosomal array synthesis approach (Fig. 
2A). The first step in this strategy was to immobilize a biotinylated, double stranded 
DNA adapter to streptavidin coated magnetic beads. The binding between the biotin and 
streptavidin occurred very rapidly and completely (data not shown). Following binding of 
the adapter, mononucleosomes were then ligated sequentially, first to the adapter, then to 
each other, with extensive washing between ligation steps. An excess of 
mononucleosomes was used in each ligation step to drive ligations to completion and 
could be observed in the ligation supernatant  (Fig. 2B, lanes “Sup 1-3”).  
To characterize the fully ligated product, the trinucleosome was liberated from the 
bead by BstXI digestion. Native gel analysis of this product (Fig. 2B) suggests that it is a 
single product with no incomplete ligation intermediates present. Further, it appears that 
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using mononucleosome with different non-palindromic overhangs prevents incorporation 
of more than one nucleosome per round of ligation.  
 
Validation of acetylation sequencing assay 
 
For nucleosome acetylation sequencing to be useful, a number of criteria must be 
fulfilled. One requirement is that acetylation signal should be due to enzyme-mediated 
acetylation of the nucleosomes, not because of non-specific acetylation or acetyl CoA 
retention. Additionally, this acetylation should be detectable with high sensitivity and 
reproducibility. To this end, we looked at acetylation levels of bead-based substrates with 
different components of the acetylation reaction present. In the absence of acetyl CoA, 
SAGA, or nucleosome, we saw that the level of acetylation was relatively low on the 
bead prior to digestion (Fig. 3A left panel) and in the supernatant after digestion (Fig. 3A 
right panel). This indicates that there was not significant signal from something besides 
the acetyl group, non-enzymatic substrate acetylation, bead acetylation, or non-specific 
acetyl CoA retention. On the other hand, when all components were present, a robust 
signal was seen on the bead prior to digestion (Fig. 3A left panel) and in solution after 
digestion (Fig. 3A right panel). This signal was significantly greater than those observed 
in our control reactions, indicating that enzyme-mediated nucleosome acetylation could 
be detected with good specificity and sensitivity. The amounts of signal on the bead prior 
to digestion and in solution after digestion were relatively similar, suggesting that 
counting on bead and in solution are comparable. However, because initial results with 
the liberated nucleosomes were more reproducible, as judged from the relatively small 
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size of the error bars relative to the total signal (Fig. 3A), all subsequent experiments 
were done in solution.  
Another requirement of the acetylation sequencing assay is that each nucleosome 
be removable from the bead quantitatively, specifically, and without disturbing the 
integrity of the nucleosomes. After wild-type trinucleosomes were acetylated by SAGA, 
they were subjected to restriction enzyme digestion and analyzed by native gel 
electrophoresis (Fig. 3B). Digestion of the acetylated trinucleosome by PflMI liberated 
nucleosome 3 specifically, as no other digestion products were observed. The liberated 
mononucleosome was also stable to the assay conditions, as no free DNA was seen. 
Moreover, the digestion was complete. Following PflMI digestion and removal of the 
liberated product, further digestion of the bead by BstXI generated dinucleosome 
product. If the PflMI digestion had been incomplete, some trinucleosome product would 
have been expected in the subsequent BstXI digestion. Similarly, digestion of the 
acetylated trinucleosome product between the first and second nucleosomes with BglI 
resulted exclusively in dinucleosome product (nucleosomes 2 + 3) with only 
mononucleosome (nucleosome 1) left on the bead. BstXI digestion of the acetylated 
trinucleosome product generated only trinucleosome product. Thus, our restriction 
digestion analysis indicates that digestion at all three restriction sites is highly efficient 
and non-disruptive. Additionally, they further support the integrity of the synthesized 
trinucleosome substrate. While these results suggest that performing multiple digestions 
is possible, subsequent experiments were performed with single digestion for consistency 
and to minimize the handling of the substrates. 
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To determine if acetylation is affected by attachment of the trinucleosome to the 
bead, assays were performed on mononucleosomes in solution and immobilized on a 
bead (Fig. 3C). Comparison of the total acetylation between the two substrates show that 
they are identical, suggesting that attachment of the nucleosomes to a bead does not 
significantly change how SAGA acetylates its substrate. 
 
Characterization of model trinucleosome acetylation 
 
Because our initial experiments demonstrated the feasibility of our acetylation 
sequencing strategy, we applied this strategy to studying SAGA-mediated nucleosome 
acetylation with different nucleosomal substrates. Our initial studies were performed 
under saturating acetylation conditions, where acetylation reactions were run with 
concentrations of SAGA near those of the nucleosome substrate (60 nM and 75 nM, 
respectively), and over long periods of time (4 hours). Under these conditions, we 
expected that nucleosome acetylation should be largely complete, and thus not differ 
significantly between the three nucleosomes. Indeed, all three nucleosomes were labeled 
to nearly the same extent under these conditions (Fig. 4A). However, acetylation 
sequencing could also report on differences in the pattern of nucleosome acetylation. 
When assays were performed under saturating acetylation conditions on a substrate in 
which the central nucleosome lacked the major sites of SAGA acetylation (Fig. 4B), 
nucleosome 2 was acetylated significantly less, while the other two nucleosomes were 
acetylated to comparable levels.  
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These experiments were also performed under sub-saturating conditions. For the 
wild-type trinucleosome (Fig. 4C), the total amount of acetylation is significantly 
diminished, as is expected because the acetylation assay was performed with significantly 
less enzyme (6 fold decrease) and time (24 fold decrease) than for the saturating 
conditions. The pattern of nucleosome acetylation is also altered. There is a preference 
for nucleosome 1, the innermost nucleosome (closest to the bead) with the other two 
nucleosomes, nucleosomes 2 and 3, showing roughly half as much acetylation. For 
experiments under similar conditions with the trinucleosome with the mutated central 
nucleosome, the central nucleosome (nucleosome 2) is poorly acetylated, while 
nucleosome 3 is again acetylated to a level of about half that of nucleosome 1.  
 
Discussion  
 
Interpretation of acetylation sequencing patterns 
 
While insightful from a qualitative perspective, the acetylation distribution can 
also provide quantitative kinetic information. During the course of an acetylation 
reaction, each nucleosome within an array competes as a substrate, where the extent of 
acetylation of a particular nucleosome depends on the strength with which it binds to the 
enzyme, its acetylation turnover, and the concentration of the unacetylated nucleosome 
[31]:  
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Where, vnuc is the instantaneous rate of nucleosome acetylation under steady state 
conditions (d[acet]nuc/dt), kcat/KM is the specificity constant, and [nuc] is the equilibrium 
concentration of free nucleosome.  
Under certain circumstances, it is possible to directly compare the relative 
amounts of nucleosome acetylation at two nucleosomes to determine their relative ratio 
of specificity constants, thereby quantifying relative substrate preference. However, 
under saturating acetylation conditions (Fig. 4A & B), this is not possible. In these 
experiments, large amounts of enzyme are used (1:1.25 enzyme to each nucleosome) and 
reactions are allowed to proceed for long times (4 hours total). Under these conditions, 
the total amount of radioactive signal corresponds to nearly 8 acetylations/nucleosome, 
suggesting complete acetylation of the major nucleosomal sites (four sites in each of the 
two H3 tails). Thus, the total amount of acetylation at each nucleosome does not reflect 
its acetylate rate (vnuc), and it would be expected that little difference in acetylation 
distribution between nucleosomes would be observed even with differences in specificity 
constants. Interestingly, under exhaustive acetylation conditions, some acetylation is 
observed for the nucleosome in which the major sites of H3 acetylation have been 
mutated to alanine (Fig. 4B). Others have observed that additional lysines on H2B can be 
acetylated by SAGA, although the extent of this acetylation tends to be relatively modest 
[19]. However, under exhaustive acetylation conditions the modification of these sites 
could account for acetylation signal above background. 
In contrast to the assays performed under exhaustive acetylation conditions, it 
should be possible to determine approximate specificity constant information for the 
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assays performed under sub-saturating acetylation conditions (Fig. 4C & D). In these 
experiments significantly less enzyme is used (1:7.5 enzyme to each nucleosome) and the 
reaction is run for a much shorter time (10 minutes). Under these conditions, the amount 
of acetylation is roughly 5% of that observed under the saturating conditions. Thus, we 
can approximate the equilibrium concentration of unbound, unacetylated nucleosome as 
the initial nucleosome concentration (i.e. [nucx] = [nucx]o). Further, because the initial 
concentrations of each unacetylated nucleosome in the trinucleosomal array are the same 
([nucx]o = [nucy]o), the ratio of their concentrations is unity (i.e. ([nucx]o / [nucy]o = 1). 
Since only 5% of the major acetylation sites appear to be acetylated, the ratio of the 
instantaneous rates for each nucleosome can also be approximated as the ratio of total 
acetylation per nucleosome (vnucx/vnucy = (d[acet]/dt)nucx/ (d[acet]/dt)nucy = (Δ[acet]/Δt) 
nucx/(Δ[acet]/Δt) nucy = Δ[acet]nucx/Δ[acet]nucy ). Using this information, our data suggests 
that nucleosomes 2 and 3 have identical specificity constants, while the specificity 
constant for nucleosome 1 is roughly 2-fold greater than the other nucleosomes. It should 
be also noted that, because of the approximations made and because not all acetylation 
sites within a nucleosome have identical acetylation kinetics, the specificity constants 
should more appropriately be referred to as apparent specificity constants. 
Because the specificity constant is composed of both kcat and KM, we cannot tell 
which kinetic parameter contributes to the apparent difference in specificity constant 
between innermost nucleosome 1 and the others. It is expected that the chemical step in 
acetylation does not differ between nucleosomes; making it likely that kcat is unaltered. 
This would suggest that the difference is due to altered KMs between nucleosomes and is 
consistent with an increased binding affinity for nucleosome 1. Unpublished data from 
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our lab suggests that SAGA has a strong affinity for free DNA, and nucleosome 1 does 
contain a longer stretch of DNA relative to the other nucleosomes. Additionally, a 
number of chromatin-interacting factors are known to show preferential binding of 
nucleosomes with large regions of free DNA [32, 33]. Future studies will be necessary to 
conclusively establish the basis for this difference in specificity.  
 
Potential extensions of acetylation sequencing 
 
Our acetylation sequencing assay can be extended a number of different ways. By 
using a more extensive range of time points, it should be possible to view the progression 
of nucleosome acetylation from initial establishment to completions to better understand 
how intermediate nucleosome acetylation states affect the course of the acetylation 
reaction. With more initial time points and variation in substrate concentrations, it may 
also be possible to perform more traditional initial rate steady state kinetics to obtain 
separate kcat and KM values for each nucleosome. To do so requires rapid quenching of 
acetylation, which should be possible because magnetic beads can be removed from 
solution relatively quickly (less than 10 seconds). Currently, our assay does not report on 
the distribution of acetylation within a given nucleosome, but our ability to isolate 
individual nucleosomes should make this feasible. Specifically, resolving the histones 
electrophoretically and detecting which bands are radiolabeled can determine which 
histones are acetylated [30]. Microsequencing of the isolated histones can determine 
which amino acids are acetylated and their extent [24]. Finally, we note that acetylation 
sequencing reactions do not require that either substrate or enzyme concentration be 
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below the KM of the reactions. This is because substrate nucleosomes are in direct 
competition with one another, and acetylation activity will simply partition between 
substrates according to the specificity factor equation described above. 
The nucleosome acetylation sequencing strategy should also be applicable to 
other substrates and enzymes. Because the on-bead solid-phase ligation strategy is highly 
modular and efficient, it should be suitable for a wide range of oligonucleosome products 
and lengths, including those incorporating mononucleosomes with different histone 
variants, post-translational modifications, DNA sequences, and DNA lengths. Studies 
with different histone modifying enzymes should be feasible, assuming that the high 
degree of specificity and sensitivity exhibited by SAGA-mediated acetylation is 
demonstrated. Finally, it should be possible to study how other chromatin-associated 
factors, such as transcriptional activators and ATP-dependent chromatin remodeling 
complexes, affect the establishment of chromatin modifications.  
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Fig. 1. Nucleosome acetylation sequencing strategy. The immobilized 
oligonucleosomal substrate is enzymatically acetylated with radiolabeled acetyl CoA and 
subsequently washed to remove unincorporated acetyl CoA. Desired nucleosomes are 
then cleaved off of the bead using specific restriction endonucleases to yield mono- di- 
and trinucleosomes. Released fragments are counted by scintillation to quantify the extent 
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of nucleosome acetylation. The acetylation pattern shown is meant as a possible example 
of differential nucleosome acetylation.  
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Fig. 2. Solid-phase synthesis of bead-bound trinucleosome substrates. (A) Schematic 
representation of substrate synthesis. A double-stranded 19 bp biotinylated adapter with a 
4 nt single-stranded overhang opposite the biotinylated end is first bound to Streptavidin-
coated magnetic beads. Mononucleosomes are then sequentially ligated, allowing 
different kinds of nucleosomes to be linked together. Unique non-palindromic restriction 
endonuclease sites are present in the linker DNA between each nucleosome. (B) 
Characterization of reactants and products in the solid-phase synthesis of bead-bound 
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trinucleosome substrate. 4% native PAGE was used to resolve mononucleosome in the 
supernatant from the ligation steps (Lanes 2-4) and to characterize the fully ligated 
product liberated from the bead by digestion with BstXI (first lane). DNA-containing 
components were visualized by SYBR Gold staining. The mononucleosome attached to 
the bead first contains 80 bp more DNA than the other two mononucleosomes. 
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Fig. 3. Demonstration of the specificity and robustness of the acetylation sequencing 
assay. (A) Investigation of the specificity of radiolabeled acetyl CoA incorporation. 
Shown are the amounts of radioactive signal after acetylation assays run with different 
components. The left panel shows signal on the beads, while the right panel shows the 
signal in the supernatant fractions. Error bars represent standard deviations from three 
independent trials. (B) Characterization of the extent of nucleosome liberation, as well as 
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nucleosome stability. Following restriction enzyme digestion, products were analyzed by 
4% native PAGE. Products of a single digestion are shown in lanes labeled with a single 
restriction enzyme. Lanes labeled with two restriction enzymes indicate that after the 
beads were treated with the first enzyme and washed, the beads were then digested with 
the second enzyme, and this liberated product was analyzed. The two bands in lane 
PflMI/BstXI are consistent with variable nucleosome positions on the same dimer DNA. 
(C) Comparison of nucleosome acetylation reaction efficiency on beads versus in 
solution. Shown is the total amount of nucleosome acetylation on the bead, where 
nucleosomes were either first acetylated and then bound to beads, or first bound to beads 
and then acetylated. Acetylation experiments were performed in triplicate. Background 
reactions (no SAGA) were performed once and subtracted from the acetylation bead 
counts. 
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Fig. 4. Acetylation sequencing of wild type and mutant trinucleosomes under 
saturating and sub-saturating acetylation conditions. Trinucleosomes were acetylated 
by the yeast SAGA complex and then subjected to acetylation sequencing. The 
trinucleosome substrate contained either three wild type nucleosomes (A and C) or two 
wild type nucleosomes flanking a central nucleosome in which the four major sites of 
SAGA acetylation (K9, K14, K18, K23) were mutated to alanine in the histone H3 tail. 
Assays were performed under saturating acetylation conditions (A and B) or sub-
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saturating acetylation conditions (C and D). Error bars represent standard deviations from 
four independent trials.  
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CHAPTER 3 
 
ACTIVATOR AND LINKER DNA MODULATE THE HAT 
ACTIVITY OF YEAST SAGA 
 
The work presented in this chapter will be submitted to a peer reviewed journal. 
 
ABSTRACT 
 
The Spt-Ada-Gcn5-Acetyltransferase (SAGA) family of co-activators acetylates 
the histone H3 tails of the nucleosomes. SAGA both maintains genome wide basal levels 
of acetylation and also establishes hyper-acetylated domains on targeted regions of 
genome, upon induction of gene transcription. To better understand how these activities 
are regulated, we were interested in how the interaction of SAGA with nucleosomes and 
chromatin-associated factors affect the activity of SAGA. Recent studies from our lab 
hinted at a preference of SAGA for nucleosomes harboring longer linker DNA. 
Expanding on those studies, we show that linker DNA both decreases the KM for 
nucleosomes by 2 fold and increases the kcat by 4 fold. Linker DNA on both sides of 
nucleosome is required for maximum stimulation, with differing amounts of DNA 
required on each side. Additionally, we show that activator proteins not only decrease the 
KM for nucleosomes, as expected, but also appear to increase kcat, uncovering a novel role 
of transcriptional activators. To better understand how SAGA activity is stimulated, we 
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probed the mechanism of turnover. We show that the first turnover is very rapid, whereas 
the subsequent turnovers are much slower, indicating that a post-chemical step, such as 
product release, is rate limiting. Overall, our results give us a better understanding of how 
SAGA works with other factors to distinguish favorable regions on chromatin from other 
regions.  
 
 
INTRODUCTION 
 
The eukaryotic genome is largely wrapped into nucleosomes, the basic structural 
unit of chromatin. Nucleosomes contain 147 bp DNA wrapped 1.65 times around a 
histone octamer containing 2 copies each of H2A, H2B, H3 and H4 [1; 2]. The frequency 
of nucleosomes is roughly every 200 ± 40 bp on an average. However, different regions 
of chromatin differ in nucleosome density and regularity of spacing. Heterochromatin 
regions, for example, are relatively uniformly spaced with a high density of nucleosomes 
to repress transcription. Euchromatin regions, on the other hand, generally have fewer 
nucleosomes on average that are more irregularly spaced, to facilitate transcription and 
other cellular processes, such as DNA replication and repair.  
The SAGA (Spt-Ada-Gcn5-acetyltransferase) family of co-activators is one such 
factor, which works in different ways to facilitate cellular processes. In yeast, it is a 1.8 
MDa multisubunit complex, which is highly conserved across all eukaryotic species [3]. 
It consists of atleast 19 different polypeptides. The Gcn5 subunit, along with Ada2 and 
Ada3 were discovered during genetic screens to identify proteins that functionally 
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interact with transcriptional activators such as Gal4VP16 [4; 5; 6].  Subsequent studies 
showed that SAGA can also directly interact with the TATA binding protein (TBP) and 
recruit it to initiate the formation of PIC. In that sense, SAGA acts as a traditional co-
adaptor, by bridging the interactions between activator and the transcriptional machinery. 
Another way it can facilitate transcription is by directly acetylating histones H3 and H2B 
on the chromatin. The Gcn5 subunit of SAGA harbors the HAT activity, and histone 
acetylation can lead to de-compaction of the chromatin, destabilization of the 
nucleosomes, and increased nucleosome mobility, thereby facilitating transcription factor 
binding [7; 8].  
Different subunits of SAGA harbor different domains, which allow it to interact 
with different aspect of chromatin. For instance, the SWIRM domain of Ada2 has been 
shown to bind to the DNA on the chromatin [9; 10]. Similarly, the bromodomain of Gcn5 
recognizes acetylated histones and helps tether SAGA on the acetylated domains [11; 
12]. This interaction seems to be specific, since the bromodomain of Spt7, another 
subunit, does not seem to participate in such an interaction. 
We have been interested in understanding the role of different features of 
chromatin, and how they impart specificity towards targeting of acetylation by SAGA. In 
order to better understand how SAGA interacts with a nucleosome in the context of 
neighboring nucleosomes, we previously developed a method, called nucleosome 
acetylation sequencing assay, to assess the spread of acetylation on each nucleosome, in a 
quantitative manner [13]. Using a trinucleosome as a substrate, we found a preference for 
nucleosomes that contain longer linker lengths than others. In order to fully understand 
this effect, we further investigated the nature of interactions between SAGA and 
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nucleosomal linker DNA.  By incorporating an activator binding site in the linker DNA, 
we were also able to take a quantitative approach to differentiate between activator bound 
targeted acetylation from untargeted global acetylation. Finally, preliminary pre-steady 
state kinetics shed light on a previously unknown mechanistic aspect of the HAT activity 
of GCN5, in context of SAGA. 
 
MATERIALS AND METHODS 
 
Nucleosomal template preparation 
The strong positioning 601-177-1 sequence was prepared as described previously 
[14; 15]. The 147 bp linker-less template was generated by PCR amplifying the region 
using the following set of primers (include primer sequences) on the template X. The 
forward primer was purchased from IDT, which was modified on the 5’ end to 
incorporate a biotin moiety with a 15 atom spacer. Other nucleosomes harboring different 
lengths of linker DNA either on one or both sides were also generated using the above 
strategy, with different sets of primers and templates. The PCR amplified templates were 
cleaned up using the PCR purification strategy from Qiagen. The purified DNAs were 
quantitated and assessed for homogeneity on a 1% agarose gel.  
 
 
Recombinant histone purification and octamer assembly 
Wild type histones H2A, H2B, H3 and H4 from Xenopus laevis were expressed 
recombinantly and purified to homogeneity, as previously [16]. The core histones were 
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used to assemble the octamer, as described before [17]. The homogeneity and integrity of 
purified histones and assembled octamer were assessed on 18% SDS PAGE.  
 
Mononucleosome assembly 
Nucleosomes harboring different linker DNAs were assembled by depositing the 
histone octamer on different lengths of template DNAs by the process of rapid dilution, 
as described previously [18; 19]. The homogeneity and degree of saturation of the 
assembled nucleosomes were assessed on a 4% Native PAGE. 
 
Immobilization of nucleosomes to streptavidin coated magnetic beads 
The nucleosome containing an extra 80 bp linker harboring Gal4VP16 target 
motif is hereby referred to as GB1XM. The preparation of GB1XM was done as 
described previously [13]. Other nucleosomes containing biotinylated DNA were directly 
attached to the streptavidin bound magnetic beads and resuspended in 1X NEB T4 DNA 
ligation buffer (50 mM Tris-HCl at pH 7.5, 10 mM MgCl2, 1 mM ATP, and 10 mM 
DTT) to get a final nucleosome concentration of 150 nM. The binding efficiency of each 
nucleosome was assessed by comparing the supernatants with known amounts of 
nucleosomal DNA on a 4% Native PAGE.  
 
ySAGA expression and purification 
Endogenous SAGA complex from Saccharomyces cerevisiae was purified using 
the TAP purification strategy, as previously [20]. The purified enzyme was quantitated by 
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using known amounts of recombinantly purified Gcn5, on a Western Blot. The activity of 
the purified enzyme was tested on synthetic H3 peptide, as before [13]. 
 
Recombinant Gal4VP16 expression and purification 
 Recombinant Gal4VP16 was purified from transformed E.coli Xa90 cells 
according to a previously published protocol, with a few modifications. Transformed 
colonies were grown in LB amp media to an O.D600 of 0.7, and were induced with 1 mM 
IPTG at 37°C for 4 hours. The cells were harvested at 4000 rpm for 20 minutes. The cells 
were resuspended in 1X lysis buffer (20 mM HEPES, 200 mM NaCl, 20 mM βME, 10 
µM Zn(Ac)2, 0.2 mM PMSF; pH 7.5) and lysed by sonication. The sample was 
centrifuged at 16000 rpm for 30 minutes. The soluble fraction was loaded on SP IEC 
column, pre-equilibrated with HEMG-100 (20 mM HEPES, 100 mM NaCl, 1 mM 
EDTA, 10 µM Zn(Ac)2,10% glycerol, 5 mM MgCl2; pH 7.5) and purified over a linear 
gradient from HEMG-100 to HEMG-1000 (20 mM HEPES, 1 mM EDTA, 1000 mM 
NaCl, 10 µM Zn(Ac)2,10% glycerol, 5 mM MgCl2; pH 7.5). The eluted fractions were 
analyzed on 15% SDS-PAGE, and appropriate samples were pooled and loaded on QP 
IEC column, pre-equilibrated with HEMG-0 (20 mM HEPES, 1 mM EDTA, 10 µM 
Zn(Ac)2,10% glycerol, 5 mM MgCl2; pH 8.5) and purified over a linear gradient from 
HEMG-100 to HEMG-1000 (20 mM HEPES, 1 mM EDTA, 1000 mM NaCl, 10 µM 
Zn(Ac)2,10% glycerol, 5 mM MgCl2; pH 8.5). Appropriate fractions were pooled and 
purified on a S-300, XK 16/40 column, pre-equilibrated with HEMG-100, pH 7.5. Pure 
fractions, as assessed on SDS PAGE, were pooled, concentrated and aliquoted in 
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different tubes. All samples were flash frozen in liquid nitrogen and stored in -80°C, until 
further use. 
 
EMSA using Gal4VP16 
Electrophoretic Mobility Shift Assays were performed on 2 nM GB1X DNA, with 
increasing concentrations of recombinant Gal4VP16 (0, 2, 4, 8, 16 and 32 nM) on a 4% 
Native PAGE, at 60V for 45 minutes in 0.5X TBE (composition). The gel was further 
stained in 150 mL 1X TBE buffer (composition) and SYBR Gold stain at RT, for 30 
minutes. The dissociation constant was estimated by quantitating the activator bound and 
free DNA on Typhoon. To demonstrate specificity towards target loci, similar assays 
were also performed on a template DNA which is identical in length to GB1X DNA, but 
does not harbor any activator binding site. 
 
Activity assays to test saturation of activity in presence of Gal4VP16 
Initial rate steady state experiments were performed using 10 nM GB1XM 
nucleosomes and increasing concentrations of Gal4VP16, to determine the activator 
concentration that would result in saturation of ySAGA activity. X µL of GB1XM 
(resuspended in LDB) were mixed with different volumes of Gal4VP16. X µL of 2X 
HAT buffer were added and the samples were equilibrated at 30°C for 5 minutes. 
Reactions were initiated by adding X µL of ySAGA, and acetylation was allowed to 
proceed. 10 µL aliquots were taken out at 0’, 3’, 6’ and 9’ and added directly to 
eppendorf tubes containing 10 µL of WB 1. The samples were washed for a total of 4 
times, at RT with WB1. They were then washed with WB 2 at 37°C for five times, with 
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25 minutes of incubation between each wash. The beads were finally resuspended in X 
µL of WB1 and added to 6/9 mL of scintillation cocktail, which were then counted in 
LSC. 
 
Steady state kinetics 
Steady state kinetics were performed on ySAGA by titrating increasing 
concentrations of nucleosomes. Reactions were performed under initial rate conditions, 
by using limiting concentrations of enzyme. Unless specified otherwise, 25 µL of bead 
bound substrate (in LDB) was mixed with 25 µL of 2X HAT buffer (composition) and 
incubated at 30°C for 5 minutes. Reactions were initiated by adding 2 nM final enzyme. 
10 µL aliquots were taken at 0’, 3’, 6’ and 9’ and were directly added to eppendorf tubes 
containing 10 µL of wash buffer 1. Each sample was washed 4 times with WB1 at RT 
and five times with wash buffer 2 at 37°C, with 25 minutes of incubation between each 
wash. The beads were resuspended in X µL of WB1 and added to scintillation vials 
containing 9 mL of cocktail. All samples were counted with LSC. The CPM obtained 
were plotted as a function of time, for each [S]. The resultant slopes were then converted 
to [P] to get kcat and KM values. 
 
Single turnover experiments 
Single turnover experiments were performed on 200 nM nucleosomes by using 50 
nM ySAGA in a final 1X reaction buffer (composition). Nucleosomes (in 2X HAT 
buffer) were equilibrated at 30°C for 5 minutes. ySAGA was then added in a final 
reaction volume of 50 µL, and incubated at 30°C for different time intervals. The beads 
  
62 
were quickly pulled to the side of the eppendorf tubes using a magnet and washed 4 times 
with 50 µL wash buffer 1 at RT followed by 50 µL wash buffer 2 at 37°C, five times with 
25 minutes between each wash. The beads were then resuspended in 20 µL WB1 and 
added to a scintillation vial containing 9 mL of scintillation cocktail. All the vials were 
counted in the LSC. The obtained counts were converted into turnovers and plotted as a 
function of time. 
 
Data fitting 
 For obtaining saturation curves, the CPM values were plotted as a function of 
time, and fitted to straight lines to generate slopes. These slopes were then converted to 
rates and plotted as a function of substrate concentration to obain KM and kcat values. The 
data obtained by performing radioactive HAT assays were converted into either amount 
of product generated, number of turnovers, or rates depending on the type of experiment. 
All data fitting was done using the software Kaleidagraph. 
 
RESULTS 
 
DNA flanking the nucleosome positioning sequence stimulates ySAGA. 
Acetylation sequencing from our lab suggested that extra DNA surrounding 
nucleosomes increases the specificity constant of SAGA toward such nucleosomes. This 
specificity constant could reflect a change in apparent binding affinity and/or a change in 
the turnover rate. However, the acetylation sequencing assay was not suited to determine 
the relative contributions of these factors. To better understand the source of specificity, 
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we developed a bead-based, initial rate, steady state acetylation assay (Fig. 1A). In this 
assay, a mononucleosome is immobilized on a bead, and the acetylation reaction is 
initiated by addition of SAGA and radiolabeled acetyl CoA. Beads were removed at 
specific timepoints, and the reaction was stopped and background reduced by washing. 
Beads were then counted to generate initial rates. A key issue that had complicated the 
analysis was the high level of non-specific background signal relative to the small 
amounts of nucleosome acetylation generated. This was overcome using multiple washes, 
including some with hydroxylamine. Hydroxylamine can cleave the thioester bond of 
acetyl CoA, and this cleaves the tritiated acetyl group from the rest of the molecule. 
Using this assay with the nucleosome that showed the greatest specificity in our 
acetylation assay, hereby referred to as GB1XM, we observed that a reproducible 
saturation curve of acetylation activity could be generated (Fig. 1B, black circles). Fitting 
these data to the Michaelis Menten equation, we found that this substrate had a KM of 21 
nM and demonstrates a kcat of 1 min-1.  
To determine how much the flanking DNA influenced SAGA activity, a second 
substrate containing only the 147 bp positioning sequence from the 601 template, with no 
linker DNA was generated (Fig. 1A). The kinetic behavior of this substrate is noticeably 
different (Fig. 1B, white circles). Its KM was 50 nM and its kcat was 0.25 min-1.  These 
kinetic constants show that addition of the flanking DNA changes both the KM and kcat for 
the substrates. Combining the effects of both KM and kcat, allows us to calculate an 
overall catalytic efficiency/specificity constant (kcat/KM) for our substrates, and indicates 
an 8-fold stimulation is observed when nucleosomes containing a long linker DNA is 
used. To investigate the possibility that immobilizing the nucleosomes with no flanking 
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DNA to the magnetic beads might be contributing to this difference, we also performed a 
control reaction where the extent of acetylation for the on-bead substrates was compared 
with a substrate free in solution. As can be seen in Fig. 1C, the reaction rate was largely 
unchanged, ruling out the possibility that the observed kinetic differences were from bead 
attachment and more generally, confirming the usefulness of the bead bound approaches.  
 
ySAGA engages linker DNA on both sides of nucleosome. 
To map how much of the flanking DNA was necessary to stimulate SAGA 
activity, we investigated substrates containing different lengths of linker DNA. Initially, 
we looked at the effect of increasing amounts of flanking DNA on just one side (Fig. 2A). 
Flanking DNA as short as 40 bp results in an increase in acetylation, as seen in Figure 
2A, although the increase was not equivalent to that of the GB1XM. Increasing the 
amount of flanking DNA to 80 bp did not increase the rate of acetylation, and the pattern 
remains similar across this regime.  
GB1XM also includes a short 15 bp linker on the other side of the positioning 
sequence (Fig. 1C). We postulated that ySAGA might engage both the linker tails to 
achieve maximum stimulation. To test this hypothesis, we investigated a nucleosome that 
contained 80 bp linker on both sides, and one with 15 bp on both sides. We found that 15 
bp on both sides result in a very modest increase in acetylation rate relative to the 
nucleosome without any flanking DNA, 147M, but much less of an increase compared to 
GB1XM. However, the nucleosome with 80 bp on both the sides showed a striking 
increase in acetylation rate relative to 147M. These data indicate that flanking DNA on 
both sides of the nucleosome are necessary for stimulation. Since the GB1XM only has 
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15 bp on one side of the nucleosome, it suggests that one side needs no more than 15 base 
pairs. On the other hand, having 15 bp on both does not provide much stimulation. Thus, 
the other side requires flanking DNA longer than 15 base pairs.  
 Because flanking DNA for the GB1XM nucleosome changes both the KM and 
kcat parameters relative to nucleosome without flanking DNA, and flanking DNA on 
both sides of the nucleosome stimulate acetylation activity, we were curious as to how 
flanking DNA individually affected the kinetic parameters. A preliminary substrate 
acetylation saturation curve was performed for nucleosomes with 80 bp on either one or 
both sides of the nucleosome (Fig. 3A). 
 
Transcriptional activator modulates ySAGA in potentially two different ways to 
ensure targeted chromatin acetylation 
SAGA is involved in the regulation of transcription of about 10% genes of a 
eukaryotic genome [21; 22]. A key question then is, how is it targeted to specific 
promoter loci to aid in inducible gene transcription? Studies have shown that one way 
this is achieved is by physically interacting with transcriptional activators [23; 24]. We 
took a quantitative approach to understand this scenario better. Towards this end, we 
incorporated a target binding site for the chimeric transcriptional activator Gal4VP16 in 
the linker DNA of GB1XM. Gal4VP16 has the DNA binding domain of the yeast Gal4 
activator, and the activation domain of the Herpes Simplex Virus. To demonstrate 
binding activity of the protein to this target locus, we performed electrophoretic mobility 
gel shift assays to resolve the activator bound DNA from free DNA. The DNA template 
used for this purpose was the GB1X DNA harboring the activator binding site. As can be 
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seen in Figure 4B, increasing amounts of activator protein results in conversion to a 
slower migrating species. As little as 3 nM results in roughly 50% loss of free DNA, and 
very little free DNA is observed with 8 nM of activator. This suggests that the activator is 
capable of DNA binding and readily saturate binding at low concentrations of activator.  
Next, we decided to perform preliminary tests to see if Gal4VP16 modulated the  
activity of SAGA in the context of nucleosome acetylation. We chose saturating 
concentrations of Gal4VP16 on GB1XM and performed nucleosomal HAT assays, as 
described. In the absence of activator, basal levels of acetylation were observed (Fig. 4C). 
However, the extent of acetylation increased to almost 10 times upon addition of 
activator. Based on the concentrations of substrate and activator used in this assay, we 
predicted an increase of about 3 fold in the acetylation if activator modulated KM alone. 
An increase of 10 fold suggests that activator not only results in tighter binding of SAGA 
on target loci containing nucleosomes, but also affects the turnover rate. In order to test 
that more exhaustively, we first performed activity saturation experiments on 10 nM 
GB1XM, by using increasing concentrations of activator, until we no longer observed 
any further increase in product formation (Fig. 4D). Now that we have results from these 
studies, we are set/ready to tease out the effect of activator on GB1XM acetylation. 
Steady state experiments will be performed on GB1XM nucleosomes, similar to what we 
did in Figure 1C, in the presence of saturating concentrations of Gal4VP16. The resultant 
KM and kcat values that will be obtained will then be compared with those obtained in 
Figure 1C, in order to get a mechanistic view of the interactions taking place between 
activator and SAGA. 
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Pre-steady state kinetics of ySAGA experiments suggest that a mechanistic step 
following acetyl transfer is rate limiting 
To better understand how acetylation turnover can be stimulated, we wanted to 
determine the rate limiting step in enzymatic turnover. In steady state kinetics, kcat 
represents the rate limiting unimolecular step and could be the chemical step, acetyl 
transfer, or could be a subsequent step, such as product release. For our assay, since 
acetylated histone is detectable on the bead even without product release, it gave us an 
opportunity to potentially directly measure the rate of the chemical step for the enzymatic 
turnover. Using saturating concentration of enzyme and substrate, we followed the time 
course of acetylated histone production (Fig. 5A). These preliminary results show that 
there is a rapid burst phase in GB1XM acetylation, where, atleast 3 turnovers are 
observed within 10 seconds. This is then followed by a linear slower phase, that has a rate 
constant comparable to what was seen in our steady state experiments. These data suggest 
that the first enzyme-mediated acetyl transfer is very fast, to the point that we cannot 
currently resolve its rate constant. This is then followed by another unimolecular 
mechanistic step that is much slower, and becomes rate limiting for subsequent turnovers. 
Thus our data suggests that the acetyl transfer step is not rate limiting, and that the rate 
limiting step in SAGA-mediated nucleosome acetylation occurs after the chemical step. 
 
Model of ySAGA towards inducible eukaryotic gene transcription 
 Based on our results, we can begin to understand how the SAGA complex might 
function in vivo. Under non inducing conditions (Fig. 6A), it can be predicted that regions 
harboring longer stretches of DNA between nucleosomes would be acetylation hot spots 
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by virtue of providing a better platform for tethering of SAGA, and in turn stimulating 
the generation of acetylated nucleosomes. On the other hand, regions containing shorter 
stretches would be less optimal substrates, and would also result in SAGA being trapped 
at such locations, since product release becomes limiting without linker DNA. Thus, one 
can imagine high occupancy of SAGA on such spots, without a corresponding increase in 
acetylation levels. As stress conditions arrive, the transcriptional activators bound to the 
UAS of target genes would physically recruit SAGA to the promoters of the stress 
induced genes (Fig. 6B). This interaction will result in rapid acetylation of nearby 
nucleosomes, thereby generating hyperacetylated domains. It is possible that other factors 
in the cell, such as remodeling complexes might act synergistically or antagonistically in 
order to achieve the desired outcome. It would be interesting to see how these factors 
work together. 
 
 
DISCUSSION 
 
We developed and utilized quantitative approaches in this study to understand the 
mechanism of acetylation mediated by the full SAGA complex, on nucleosomal 
substrates. By generating nucleosomes that harbored different lengths of flanking linker 
DNA, we show that the length of this DNA differentially regulates the activity of 
ySAGA. Long stretches of DNA stimulate this activity by not only creating a platform 
that results in tighter binding, but also modulating the catalytic activity towards more 
efficient turnover. We also show that transcription activators work in more than just 
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potentiating tighter binding of SAGA on target loci. We show for the first time, that these 
activators also stimulate SAGA for faster turnover, by affecting the catalytic efficiency. 
By optimizing in vitro acetyltransferase assays, we also demonstrate for the first time that 
SAGA undergoes burst phase kinetics, indicating that the first acetyltransferase step is 
very rapid. Subsequent step, such as product release, is rate limiting which results in a 
slower, linear second phase.  
 
Potential acetylation hotspots on genome 
 
The eukaryotic genome has a highly dynamic chromatin landscape that evolves 
rapidly in response to changes in extracellular and intracellular conditions [25; 26]. One 
of the features of this landscape is the spacing between tandem nucleosomes. For 
example, nucleosomes in the heterochromatin regions consist of regularly phased arrays, 
which results in dense packing of nucleosomes to create transcriptionally repressive 
domains [27]. Studies have shown that members of ISWI family of remodelers, such as 
ACF, are actively involved in creating such domains [28]. ACF has been shown to be a 
DNA ruler, and is modulated by the lengths of free DNA flanking the core positioning 
nucleosomal DNA. By utilizing the energy obtained from hydrolysis of ATP, ACF slides 
the nucleosomes to centrally positioned nucleosomes [29]. 
Recently published studies from our lab hinted that ySAGA might have 
preferences for longer stretches of linker DNA [13]. To explore further into this scenario 
required a sensitive and reproducible assay, which is conducive to steady state kinetics 
using nucleosomes as substrates. Towards this end, we developed a bead based assay 
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which allowed us to immobilize biotinylated nucleosomes to streptavidin conjugated 
magnetic beads. Optimizations were done to achieve high signals in a reproducible 
fashion, and more importantly, low background levels. Using this assay, we were able to 
test the effect of linker DNA on the activity of ySAGA, and found that indeed, longer 
linker DNA containing nucleosomes are better targets over linker-less nucleosomes. Our 
results suggest that nucleosomes that have long flanking linker would be hot spots for 
acetylation by SAGA, in the eukaryotic genome. Note that SAGA binds linker-less and 
sub-optimal nucleosomes with nanomolar affinities too, thereby explaining how it is able 
to establish untargeted basal levels of acetylation genome wide. We argue that 
nucleosomes with longer linkers contribute to acetylation hotspots and result in hyper-
acetylation domains, above from basal levels of acetylation.   
 
Targeting of SAGA at specific loci by transcription activators uncovers a novel effect of 
this interaction 
 
Gcn5 was discovered along with Ada2 and Ada3 during genetic screens to 
identify factors which interacted with transcriptional activators. Subsequent studies 
confirmed that the full SAGA complex is recruited at different promoters by the 
respective activator proteins. Additional subunits, such as Tra1 have been shown to be 
involved in this interaction [30; 31]. These responses are often quite rapid in order to 
achieve homeostasis, and so far, qualitative studies have been performed to understand 
this interaction. We were interested in taking a quantitative approach to gain further 
insights into the mechanism of this interaction. Our preliminary results suggest that 
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activators mediate this by physically recruiting SAGA to target loci, in excellent 
agreement with previous studies. We also discovered a previously unknown mechanism. 
The physical interaction between activator and SAGA also modulates the catalytic 
activity to result in much faster turnover, almost as much as 10 times. This explains how 
the cell is able to quickly respond to the upstream stimuli and turn inducible genes on. 
Past studies have shown that upon targeted recruitment, SAGA establishes a very 
restricted region of hyperacetylation in vivo, spanning roughly 2-3 nucleosomes, in 
contrast to other HAT complexes such as NuA4 [32]. It would be interesting to watch the 
extent of spread of this acetylation in vitro, quantitatively. It would also be interesting to 
uncover the source of this stimulation. Mutant SAGA complexes and mutant activator 
proteins will shed a light on this aspect, to further our understanding.  
 
Burst phase kinetics of SAGA hint at rate limiting product release 
 
Our bead based assay allowed us to perform single turnover kinetics which led us 
to discover an unprecedented feature of the acetyltransferase reaction mechanism. The 
first chemical step of acetyl group transfer to the histone tail is quite rapid and results in a 
burst phase. We observed as many as 3 turnovers in under 10 seconds under these 
conditions. In contrast, subsequent cycles were much slower, and linear, suggesting a step 
after the chemical step, such as product dissociation, or conformational change, might be 
the rate limiting step. This might also suggest that in vivo, SAGA might get stuck on 
some loci because of this. The functional ramifications of this would be interesting. The 
source of this burst phase and the nature of the rate limiting step are currently under 
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investigation. In our current set up of these assays, it is very difficult for us to go less than 
10 seconds in a reproducible fashion. We are trying to optimize our reaction conditions 
that would allow us to chase the burst phase in a more quantitative manner. We are also 
in the process of repeating above experiments to get a reproducible rate constant. The rate 
constant for the slower, linear phase obtained from our single turnover experiments was 
found to be very similar to the one obtained from our steady state experiments, further 
validating our results. The next set of experiments will be performed in similar manner as 
above, with different concentrations of SAGA, to show a linear dependence of amplitude 
as a function of enzyme concentration. We will also be employing 147M nucleosomes to 
investigate if the source of this burst phase is due to longer flanking linker. 
Overall, through our quantitative approaches, we now have a better picture of how 
SAGA maintains some substrate specificity and also how it is able to work along with 
other factors in the cell to ensure the ultimate success of the organism.  
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Figure 1. Linker DNA stimulates ySAGA mediated nucleosomal acetylation. (A) 
Schematic representation of the nucleosomes (left panel) and assay (right panel) used. 
The nucleosome containing the longer linker DNA and activator binding site is referred 
to as GB1XM and contains 95 base pairs on ones side of the core nucleosome, and 15 on 
the other. The nucleosome containing only the 147 bp positioning sequence is referred to 
as 147M and contains no base pairs flanking the core nucleosome. (B) Steady state 
kinetics analysis to determine the mechanistic factors contributing to the difference in 
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observed acetylation. (C) Comparison of acetylation for immobilized nucleosomes and 
nucleosomes free in solution.
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Figure 2. Determination of the features of DNA flanking the nucleosome that 
stimulate ySAGA. (A) Comparison of the acetylation effects for substrates containing 
different lengths of flanking DNA on a single side of the nucleosome. Shown are a 
schematic representation of the substrates tested (above panel) and a bar graph showing 
the associated extents of acetylation (lower panel). (B) The effects of proximity of the 
linker DNA to the bead were tested by constructing templates harboring the linker on the 
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opposite side (upper panel). The extents of acetylation are shown below (lower panel). 
(C) Comparison of the acetylation effects of substrates containing different lengths 
flanking DNA on both sides of the nucleosome. The upper panel shows a schematic of 
the substrates tested and the lower panel compares the associated extents of acetylation.
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Figure 3. (A) Steady state kinetics performed on nucleosomes that harbor 80 bp linker on 
one or both sides of the positioning sequence. (B) A table summarizing the kinetics 
constants obtained using different nucleosomes.  
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Figure 4. Effect of activator protein on nucleosomal acetylation. (A) Assessment of 
the homogeneity of purified Gal4VP16 on 15% SDS PAGE. (B) Analysis of activator 
binding to DNA. Electrophoretic mobility gel shift assays were performed using GB1X 
DNA and increasing amounts of recombinantly purified Gal4VP16 were titrated with 2 
nM DNA. Activator-DNA complex was resolved from the unbound DNA by 4% Native 
PAGE and stained with SYBR-Gold (C) Extent of GB1XM nucleosome acetylation with 
or without saturating amounts of Gal4VP16 activator. (D) Pilot nucleosome activation 
saturation study.  
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Figure 5. Mechanistic analysis of acetylation turnover, kcat. (A) Shown is a plot of 
product turnovers as a function of time under conditions where enzyme and substrate 
concentrations significantly above KM (200 nM GB1XM and 50 nM ySAGA, 
respectively). Product turnover is calculated from the concentration of acetyl-lysine 
produced divided by the concentration of SAGA. Pre-steady state acetylation occurs 
before the first time point, and the post-steady state behavior is fit to the linear equation 
shown.  
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Figure 6. A model of potential interactions between SAGA, chromatin and transcription 
activators to regulate eukaryotic gene expression. 
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CHAPTER 4 
 
ADDITIONAL DATA AND FUTURE STUDIES 
 
We have been working towards gaining a more comprehensive picture of the 
mechanisms employed by the SAGA complex, either by itself, or in conjunction with 
additional factors, to regulate eukaryotic gene expression. This section describes our on- 
going studies, which will be optimized further to accomplish our overall goal. 
 
 
Exhaustive mapping of linker requirements 
 
 We are currently mapping the features of linker DNA that modulate the HAT 
activity of the SAGA complex. We have already designed an exhaustive library of 
nucleosomes differing in lengths of linker on both sides of the core positioning sequence. 
The next thing to do is to perform standard HAT assays under conditions mentioned 
before, and compare the extents of acetylation across the entire panel. We aim to obtain 
information such as length, orientation and sequence preferences of SAGA. 
 
Using minimal enzyme and minimal substrate systems 
Previous studies showed that a subcomplex containing Gcn5, Ada2 and Ada3 can 
recapitulate the HAT activity of the full complex. We started by comparing the kinetic 
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properties of the full SAGA complex with the minimal SAGA complex, which we call as 
the subcomplex, on synthetic H3 peptides. We were interested in seeing if modules or 
domains outside the HAT module potentially regulates the acetyltransferase activity of 
SAGA. Figure 1 shows steady state saturation curves obtained by using WT SAGA and 
WT subcomplex on increasing concentrations of the H3 peptide.  
  
Using minimal enzyme on nucleosomal substrates 
 
With the beads based assay optimized to perform steady state kinetics, a wealth of 
information can be generated by using different forms of SAGA (WT and mutants), and 
by changing the characteristics of the nucleosome. 
The significant differences observed between SAGA and subcomplex on peptides 
prompted us to test the system in the other way too, by using subcomplex on 
mononucleosomes. We were curious to see if similar differences might be seen using 
chromatin substrates. Fig 2 shows our preliminary results obtained. 
Future experiments  
 
More applications of the bead-based assay 
 
The bead-based assay can also be utilized to gain more insights to explain 
biologically relevant scenarios. For instance, we can incorporate histone variants, such as 
H2AZ, which is usually found in the promoter regions of actively transcribing genes. It 
would be interesting to see if the kinetic parameters obtained by using such a substrate 
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can explain locus specific presence. Similarly, we can incorporate H3 histone which is 
acetylated on all the four primary sites targeted by SAGA (14, 18, 9, 23), or mutated into 
alanine to so it can’t be further acetylated. It would be interesting to see how these 
substrates would change the kinetics of turnover.  
 
More applications of the nucleosome acetylation sequencing strategy 
 
Using the nucleosome acetylation sequencing strategy, we can incorporate 
different kinds of nucleosomes in tandem and observe how the spread of acetylation 
across these systems differ. For instance, we can incorporate histone variants on one of 
the nucleosomes, or build a system that has different post-translational modifications on 
the neighboring nucleosomes. We can also vary the spacing between nucleosomes to see 
how things change. The promoter region of active genes, for instance, has a nucleosome 
free region flanked by nucleosomes harboring H2AZ, instead of the core H2A. It would 
give us clues to how the modification landscape on chromatin evolves with respect to 
neighboring environment.  
 
 
Discovering domains/modules involved in regulating HAT activity of SAGA 
 
We would ultimately like to map the modules/domains within full SAGA 
complex that are responsible for above activities. For instance, the SANT domain of 
Ada2 has been shown previously to have the ability to bind naked DNA. An obvious 
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direction would be to create a SANT Δ yeast strain and purify SAGA from it. It would be 
interesting to see if that abolishes the preference towards longer linker DNA, that we 
observed for the WT strain. Results from this study would shed light on the role of SANT 
domain and other potential domains involved. Similarly, we would also like to perform 
steady state experiments using Gcn5Δ and bromodomain Δ strains to understand the 
source of burst phase and also preferences towards linker DNA.  
The effect of different modules on the activity of the HAT module is currently 
being investigated by another graduate student in the lab, Sannie Olson. She generated 
some knockout strains and her preliminary results . She is currently in the process of 
generating more knockouts, to get a more comprehensive picture. Current studies involve 
histone peptides as substrates, and filter binding assays. I will be performing bead-based 
assays on nucleosomal substrates to study differences observed. The work from this 
collaboration will be published as a paper in a peer reviewed journal, and I will be an 
author on it.  
 
Investigating the source of burst kinetics 
 
 We are interested in investigating the source of the burst kinetics that were 
observed by using GB1X nucleosomes. Our first experiment will be to perform similar 
experiments using the linkerless 147 bp nucleosome, to test if the linker DNA contributes 
to the rapid first turnover. In addition, we will also perform above experiments by adding 
Gal4VP16 in our reactions, to see if the presence of activator changes the kinetic 
properties under single turnover conditions.  
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Ultimately, we would also like to optimize our assay to be able to perform true 
pre-steady state experiments. Towards this end, we will have to try a quenching 
mechanism that does not disrupt the structural integrity of the nucleosome, and would 
allow us to perform these experiments in the millisecond phase, to extract the true burst 
constant.  
 
 
Gaining better understanding of activator effect 
 
 The current studies probing into the mechanism of transcriptional activators will 
include performing steady state experiments under initial rate conditions, by using 
increasing concentrations of GB1X nucleosomes and saturating concentrations of 
Gal4VP16, similar to Figure 1C in chapter 1. It would be interesting to see the effect of 
activator on the kinetic properties of SAGA. We will also perform similar experiments on 
147 bp nucleosomes, under conditions that allows specific binding of activator to target 
sequence. Thus, it would be interesting to see if activator can mediate any effect 
independent of target locus binding. Any difference observed will suggest new 
mechanisms, and thus will further our understanding. These effects can also be mapped 
by utilizing mutant activator proteins, to tease out the role of different domains in the 
activator protein. Towards that end, it would also be useful to employ different forms of 
SAGA complex, such as subcomplex and other deletion mutants that result in loss of a 
subunit or a module. Previous studies have shown that Tra1 is an activator interacting 
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subunit of SAGA, but it might not be the only one. Above results will uncover additional 
activator interacting domains within the full complex. 
 We also generated different activator knockout yeast strains. As shown in Figure 
3, the knockout strains grow poorly under respective stress conditions. These activators 
require Gcn5 in vivo, to initiate gene transcription. These knockout strains are valuable 
tools for performing in vivo studies, such as ChIP to monitor changes in SAGA 
occupancy on target loci. 
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Figure 1. Comparison of kinetic properties between endogenous SAGA and 
recombinant subcomplex. (A) The recombinantly expressed subcomplex was purified to 
near homogeneity. (B) Steady state kinetics were performed using full SAGA and the 
subcomplex, on synthetic H3 peptides. (C) Silver stain analysis of purified SAGA 
complexes from different knockout yeast strains. (D) Summary of kinetic parameters 
obtained from different Gcn5 containing complexes.
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Figure 2. Reaction progress of recombinant subcomplex on GB1X nucleosomes. 
Shown is a plot of turnovers as a function of time. 2.5 nM subcomplex was used to 
initiate the HAT reaction on 40 nM nucleosomes. 
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Figure 3. Plate growth assays of different yeast strains. Different knockout and mutant 
strains were generated and grown under different stress conditions. (A) Serial dilutions of 
WT, Gcn5Δ, and Gcn5 BD mutants were grown under the absence of tryptophan (left 
panel). When the corresponding activator, Gcn4, was deleted, the growth phenotype is 
worse (right panel), validating activator KO strains as useful tools to perform in vivo 
studies. (B) Serial dilutions of WT, Gcn5Δ, and Gcn5 BD mutants were grown under the 
absence of galactose (left panel). Deletion of Gal4 results in worse phenotype (right 
panel)
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CHAPTER 5 
 
CONCLUSIONS  
 
The low resolution crystal structure of a nucleosome, and identification of p55 
from Tetrahymena as a histone acetylating enzyme remain the two most crucial 
discoveries in the field of chromatin, in my opinion. These studies provided a great 
impetus to understand chromatin, beyond acting as a store of genetic material. Soon it 
was appreciated that it indeed is a complex and dynamic structure that is essentially 
involved in a plethora of cellular processes such as DNA replication, repair, transcription, 
stress survival and development. More and more processes are now being linked with 
chromatin, such as metabolism and circadian rhythm, which makes sense since gene 
expression regulates the overall success of an organism.  
Soon after demonstrating the HAT activity of p55, Gcn5 it’s yeast ortholog was 
also shown to possess this activity, suggesting lysine acetylation of histones is a highly 
conserved mechanism to regulate chromatin, across species. Higher eukaryotes, from 
Drosophila to humans, were subsequently shown to harbor Gcn5, establishing this fact. 
Elegant in vitro studies were performed on different histone peptides by using 
recombinant HAT domain of Gcn5 and it was shown that Gcn5 targets lysine 14 on 
histone H3. However, unexpected results showed that it failed to acetylate core histones 
and mononucleosomes, the basic structural unit of chromatin. This led to purification of 
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Gcn5 from biological sources, such as Saccharomyces cerevisiae, and shown that Gcn5 is 
a part of large multisubunit complexes, that were chromatographically different.   
 Subsequent characterization using various biochemical and structural approaches 
proved that despite having large overlaps in subunit compositions, these complexes were 
indeed distinct from each other by virtue of regulating distinct/unique cellular processes. 
This also explained why recombinant Gcn5 alone could not acetylate histones or 
nucleosomes. Gcn5’s specificity is expanded in the context of these complexes, and it can 
now target all forms of chromatin. It can also acetylate H3K14, 18 9 and 23, and also 
H2B, to a lesser extent. Other enzymes were also shown to work differently in the 
context of their respective complexes. Context is a very important theme in chromatin 
biology. While it is certainly important to understand the role of any protein or histone 
modification in isolation, and quite often is a necessary step towards understanding the 
bigger picture, it should always be kept in mind that in vivo, this is often not the case and 
thus, the next step is to study the roles of these factors in combination with other factors. 
Towards this end, our lab has been investigating the role of different aspects of 
chromatin, i.e., the role of acetylation, methylation and the nature of higher order 
chromatin structures to gain a more comprehensive view of how different factors work in 
a concerted fashion to regulate biology. My attempt during these past 6 years has been to 
further this knowledge and advance the field. Specifically, I have been working towards 
understanding the function of the SAGA complex, one of the three Gcn5 containing 
complexes, from Saccharomyces cerevisiae. As mentioned before, SAGA is highly 
conserved across all eukaryotes, with large overlaps in subunit composition and 
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functions. Thus, the knowledge gained out of this project is predicted to help us 
extrapolate the information to higher eukaryotes such as humans, in an educated manner. 
SAGA harbors two different enzymatic functions, the acetyltransferase activity contained 
in Gcn5, and a ubiquitin protease activity harbored by Ubp8. These activities are present 
in distinct modules within the complex, and are often independent.  
My work has been aimed towards characterizing the HAT activity of Gcn5 in the 
context of full complex towards chromatin substrates, such as nucleosomes using in vitro 
approaches. Denu and coworkers previously characterized the HAT domain of 
recombinantly purified Gcn5 on peptide substrates, also using in vitro approaches. 
Elegant experiments established that Gcn5 forms a ternary complex with acetyl CoA and 
histone and catalyzes a direct transfer of the acetyl group to the histone. This reaction 
follows an ordered Bi-Bi mechanism whereby acetyl CoA binds the catalytic domain of 
the enzyme before histone. Following catalysis, acetylated histone leaves first followed 
by CoA.  
These experiments were pioneering towards a better understanding of chromatin 
acetylation by histone acetyltransferases. However, the studies utilized highly simplified 
substrates. For instance, only the HAT domain of Gcn5 was used as the enzyme. The 
substrates were simple too, being short peptides from the amino terminal tails from 
histones. In vivo scenario is much more complex. As mentioned before, Gcn5 does not 
act alone, but rather in context of large multisubunit complexes. Also, it targets 
chromatin, which constitutes of nucleosomes present in an array fashion. Therefore, we 
started by purifying endogenous SAGA complex from Saccharomyces cerevisiae. For 
our substrates, we employed the well characterized 601 template, which is a strong 
  
96 
nucleosome positioning sequence. We realize that this is not a naturally occurring 
sequence and in vivo, nucleosomes of all sorts of stabilities are observed. However, for 
our in vitro studies, it is important that the substrate used is homogeneous and stable so 
that we get reliable and reproducible results.  
The first challenge that we tackled was to develop a reliable, reproducible and a 
sensitive assay to be able to perform kinetics using nucleosomes as a substrate. Filter 
binding assays offer great potential for peptide substrates, which is routinely used in our 
lab. However, these peptides are usually positively charged due to the basic nature of 
histones. Also, they are quite stable and thus spotting them on filters doesn’t compromise 
their integrity. Nucleosomes, on the other hand, are overall negatively charged and quite 
fragile. With these caveats in mind, we tried using filter binding in our studies, but found 
that such an approach is not well suited for substrates such as nucleosomes. This 
necessitated development of an alternative method.  
The work described in chapter 2 was my contribution towards it, in collaboration 
with Dr. Melissa Blacketer in the lab. We turned our efforts towards developing a bead 
based assay, wherein the nucleosomal substrates were designed to incorporate a biotin 
moiety, which would allow us to immobilize them to streptavidin conjugated magnetic 
beads. An added advantage of developing such as strategy was the fact that multiple 
nucleosomes can be ligated in tandem, thus allowing us to study a specific nucleosome, 
in the context of neighboring nucleosomes. We showed that attaching nucleosomes to the 
beads does not compromise the ability of ySAGA to acetylate the target residues. The 
efficiency of the reaction was similar to one where substrates are present in solution. We 
also showed that substrates ligated with 100% efficiency and were stable throughout the 
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assay period. By incorporating different endonuclease sites in the linker DNA, we were 
also able to liberate the nucleosomes into solution in a reproducible and efficient manner, 
thereby allowing us to do quantitative studies. We call this strategy as nucleosome 
acetylation sequencing strategy. We were interested in studying the patterns of 
acetylation established across multiple nucleosomes.  Using a trinucleosome substrate, 
we started comparing the extent of acetylation across individual nucleosomes, and found 
that under saturating acetylation conditions, all nucleosomes were targeted to similar 
extents, as long as they harbor wild type, unacetylated targets. Differences started to 
unravel under limiting conditions, and interesting patterns were observed. We observed 
that when one of the nucleosomes was flanked by a much longer linker DNA than others, 
it was a preferred target over nucleosomes flanked with shorter linkers. This got us 
intrigued and we decided to pursue it further, which is described in more detail in chapter 
3. In summary, our nucleosome sequencing strategy is highly modular, reproducible and 
sensitive. It can also be easily adapted to other systems to understand the working of 
other chromatin modifying complexes. 
The results obtained from our work in chapter 2 got us intrigued to pursue the role 
of linker DNA on SAGA mediated nucleosome acetylation. We decided to use 
mononucleosomes for these studies. A new challenge now was to optimize the above 
bead based strategy to make it suitable for steady state kinetics. Once that was 
accomplished, we designed nucleosomes that were flanked with different lengths of 
linker DNA and attached all of them to the streptavidin coated magnetic beads. Steady 
state and initial rate reactions were performed on these substrates and we found that the 
length of the linker DNA has a profound effect on the activity of ySAGA. Nucleosomes 
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with longer linkers, and linkers on both sides of positioning sequence are better targets. 
This stimulation is not only due to better binding, as one would expect, but linker DNA 
modulates the kcat too, thereby increasing the overall turnover efficiency. Further, it 
appears that ySAGA engages not only a long linker, but also linker DNA on both sides of 
the core positioning sequence to achieve maximum potential. We are currently in the 
process of investigating this in an exhaustive fashion to gain a better understanding of 
this preference.  
Another aspect that has been of interest to us is to understand the mechanism of 
targeted histone acetylation by SAGA. Only about 10% of yeast genes are under the 
regulation of SAGA. How is this specificity maintained. Several models have been 
suggested, and physical recruitment by a transcriptional activator has been most studied. 
It is thought that the activation domain of an activator directly interacts with SAGA, to 
recruit it to specific loci on the genome. To understand this effect in a more quantitative 
manner, we incorporated binding site of a well studied activator, Gal4VP16, in the linker 
DNA of one of the substrates. Preliminary studies suggest that activator stimulates 
nucleosomal acetylation beyond linker DNA, in potentially two ways, by affecting the 
binding affinity and by modulating the turnover rate. This might explain how the cell is 
able to quickly respond to environmental and cellular stresses. These studies are very 
preliminary at this stage, and we are currently working towards gaining better insights 
into the mechanistic aspects.  
Finally, we are also characterizing the enzyme using pre-steady state kinetic 
approaches. Using GB1XM nucleosomes as substrates, we found that ySAGA undergoes 
a burst phase, which is suggestive of a rapid chemical step. It is then followed by a 
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slower, linear phase which we captured earlier during our steady state experiments. So 
far, we believe that a step subsequent to catalysis, such as product release, is rate limiting. 
We are also working towards performing more exhaustive kinetic experiments to 
understand the source of this burst phase.
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Abstract 
Lysine acetylation is a common post-translational modification, which is especially prevalent 
in histone proteins in chromatin. A number of strategies exist for generating histone proteins 
containing lysine acetylation, but an especially attractive approach is to genetically encode 
acetyl-lysine residues using nonsense suppression. This strategy has been successfully 
applied to single sites of histone acetylation. However, because histone acetylation can often 
occur at multiple sites simultaneously, we were interested in determining whether this 
approach could be extended. Here we show that we can express histone H3 proteins that 
incorporate up to four sites of lysine acetylation on the histone tail. Because the amount of 
expressed multi-acetylated histone is reduced relative to the wild type, a purification strategy 
involving affinity purification and ion exchange chromatography was optimized. This 
expression and purification strategy ultimately generates H3 histone uniformly acetylated at 
the desired position at levels and purity sufficient to assemble histone octamers. Histone 
octamers containing four sites of lysine acetylation were assembled into mononucleosomes 
and enzymatic assays confirmed that this acetylation largely blocks further acetylation by the 
yeast SAGA acetyltransferase complex. 
 
 
 
 
 
 
  
102 
 
Introduction 
Lysine acetylation is a pervasive post-translational protein modification, where 
approximately 3,600 sites of lysine acetylation in over 1,700 different proteins have been 
identified through proteomic studies of human cells [1]. This modification helps to regulate 
proteins with a wide range of functions, including those involved in metabolism [2], cell 
structure [3], and cell signaling [4].  
Histone proteins that comprise chromatin constitute an especially large class of 
acetylation targets. Histone proteins H2A, H2B, H3 and H4, are highly basic proteins that 
contain a high density of lysine residues. Two copies of each of these proteins can form a 
histone octamer, around which DNA can wrap to form a nucleosome [5], the fundamental 
structural unit of chromatin. In nucleosomes, the bulk of the histone sequence is contained 
within the wraps of the DNA in the globular histone domain. However, less structured 
regions of each histone extend past the DNA to form histone “tails.” At least thirty different 
sites of lysine acetylation have been identified in histones, with multiple sites identified in 
each [6]. Modifications occur both in the globular and tail regions of the histone, although a 
significantly greater number of sites are present in the histone tails. 
One strategy, to better understand how histone acetylation affects chromatin structure 
and function, is to reconstitute chromatin in vitro using acetylated histones. In this strategy, 
the main challenge is to obtain histones that contain lysine acetylation at the desired sites. 
Direct purification of uniformly acetylated histones is generally impractical, because the 
heterogeneity of acetylation sites coupled with their similar physical properties makes 
isolation difficult. Enzymatic acetylation of histones has had some success. However, 
ensuring that only desired lysines are acetylated, and are acetylated fully, is often not easy 
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[7]. As an alternative, we have previously adapted the strategy of native chemical ligation to 
incorporate a range of histone modifications in the H3 and H4 tails [8, 9]. In this strategy, a 
histone tail peptide containing desired modifications is generated by standard solid-phase 
peptide synthesis strategies, and then ligated to a recombinantly expressed histone fragment 
corresponding to the remaining sequence. This strategy yields uniformly modified, full-
length histone in reasonable yields. However, because peptide synthesis is relatively costly, 
and the steps involved are laborious, we were interested in exploring alternative strategies for 
incorporating different patterns of lysine acetylation into the histone tails. 
A promising strategy that has recently been applied to generating acetylated histone is 
nonsense suppression expression. In nonsense suppression expression [10], the idea is to 
genetically encode for a non-standard amino acid that becomes incorporated during 
translation. In its most common form, the non-standard amino acid is introduced into a 
specific site in a protein by first mutating its sequence to an amber stop codon. By including 
a modified tRNA that contains an amber anticodon and a site for attaching a desired 
nonstandard amino acid, as well as a tRNA synthetase that can charge the tRNA with the 
desired amino acid, the nonstandard amino acid becomes incorporated into the protein during 
translation. Chin and coworkers showed that a modified pyrrolysyl- tRNA synthetase derived 
from M. barkeri can efficiently charge a tRNA with acetyl-lysine, and that this residue can be 
incorporated into histone H3 with good yields [11].  With this strategy acetyl-lysine was 
incorporated at multiple sites within the H3 histone. However, in all cases, each histone 
contained only a single acetyl-lysine. 
 In vivo, acetylation of multiple sites within the same histone is common [12], where 
the pattern of this acetylation can change the binding of chromatin-associated proteins or 
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directly change chromatin structure and stability. For examples, dual bromodomains found in 
a number of nuclear proteins recognize and bind to specific pairs of lysine acetylation, 
thereby targeting these proteins to specific chromatin regions [13]. Similarly, because lysine 
acetylation reduces the total change on histone tails, multiple acetylations can work 
synergistically to reduce the folding of chromatin into 30 nm fibers and reduce its stability 
[14, 15]. Because of our interest in how different combinations of lysine acetylation can 
modulate the structure and function of chromatin, we were interested in exploring to what 
extent this strategy could be extended to incorporating multiple sites of acetylation within a 
single H3 histone. 
 
Materials and Methods 
Plasmid Production 
Xenopus laevis H3 histone in a pET3c expression plasmid [16] was mutated to incorporate 1-
4 amber codons by sequential application of Quikchange mutagenesis (Strategene). The 
mutated H3 histone ORFs were then cloned into a pCDF-PylT-H3K14amb plasmid to 
replace the single amber codon containing H3 histone [11]. 
 
Expression of acetylated histone H3 
Expression methods were adapted from those previously published [11]. BL21 DE3 cells 
were co-transformed with the pAcKRS-3 plasmid containing the tRNA synthetase and the 
pCDF-PylT plasmid containing both the H3 histone with the desired number of amber 
codons and the amber suppressor tRNA. Transformed cells were grown overnight at 37°C in 
50 mL standard Luria Broth media under selection of 50 µg/ml kanamycin and 50 µg/ml 
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spectinomycin. 250 mL of prewarmed non-standard 2xYT broth (2xYT-KS: 0.5% w/v 
sodium chloride, 1% w/v yeast extract, 2% w/v tryptone), containing 50 µg/ml kanamycin 
and 50 µg/ml spectinomycin, was inoculated with overnight culture to a final OD600 of 0.08 at 
37°C. The dilute 2xYT-KS culture was grown to 0.7 OD600. N-ε-Acetyl-L-lysine (≥98% 
pure, Novabiochem) was then added to a final concentration of 10, 20, 40, or 80 mM. 
Nicotinamide (NAM) was added to a final concentration of 20 mM. After 30 minutes, protein 
expression was induced with the addition of 0.5 mM IPTG. After 4 hours, 250 mL cultures of 
cells were pelleted and resuspended in 30-ml of Wash Buffer (WB: pH 7.5, 50 mM Tris-HCl, 
100 mM NaCl, 1 mM Na-EDTA, 1 mM benzamidine, 1 mM DTT, 20 mM NAM) then 
frozen at -80°C overnight. 
  
Purification of acetylated histone H3 
Inclusion bodies from 250 ml of culture were isolated as previously described [17]. The 
insoluble final pellet containing histone was macerated with 0.25 mL DMSO and then 
thoroughly resuspended in 15 mL unfolding buffer (UB: 6M guanidine hydrochloride, 20 
mM Tris hydrochloride, 5 mM β mercaptoethanol, pH 8.0) and stirred at room temp for 1 
hour. The mixture was clarified via centrifugation (12,000 RCF, 10’). The supernatant was 
added to 2.5 mL of pre-equilibrated and drained Ni2+-NTA Bead Resin (Qiagen) in a 30-ml 
disposable column and stirred at room temperature for 1 hour. The column was drained and 
the resin washed two times with 30-ml Guanidine Wash Buffer (GWB; 6M guanidine 
hydrochloride, 100 mM monosodium phosphate, 5 mM β-mercaptoethanol, pH 6.3). The 
resin was then washed with 100 mL 1X TEV Cleavage buffer (50 mM Tris hydrochloride, 50 
mM imidazole, 0.5 mM EDTA, 5 mM β mercaptoethanol, pH 8.0). The resin was 
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resuspended in 23 mL 1X TEV cleavage buffer and 10,000 units of TURBOTEV protease 
(Nacalai USA) were added. Digestion was carried out with nutation for 16 hours at room 
temperature.  The column was then drained and resuspended in 15 mL UB and stirred at RT 
for 1 hour. UB eluent containing histones was dialyzed into SAU buffer (7M urea, 20 mM 
sodium acetate, 1 mM DTT, 1 mM sodium EDTA, pH 5.2). The histone sample was then 
purified via cation exchange on a salt gradient from 0 mM to 600 mM NaCl over 225 mL 
using a HiTrap SP HP 5 mL column (GE Life Sciences). Histones eluted in a highly pure 
state and were concentrated and desalted using Sep-Pak C-8 reverse phase purification 
columns (Waters) before lyophylization. Purified acetylated histone H3 was checked via 
MALDI-TOF analysis to verify the correct number of acetylations were present (John Leszyk 
at University of Massachusetts Medical School). Histone was quantified using densitometry 
against standard curves of H3-tetra-alanine containing histone. 
 
Assembly of Mononucleosomes 
Wild type histones and the tetra-alanine H3 histone were expressed, purified, and quantified 
according to literature protocols [17]. 177 bp DNA templates containing the 601 strong 
positioning sequence [18] and BglI non-palindromic sticky ends were prepared as previously 
described [19]. Octamers were assembled from the appropriate recombinant histones and 
purified via size exclusion chromatography as published previously [17]. Mononucleosomes 
were reconstituted from the DNA template and histone octamer via rapid dilution methods 
[20], and then were characterized via 4% native PAGE Gel with staining for the DNA. The 
assembled nucleosomes were dialyzed into native buffer (2.5 mM NaCl, 10 mM Tris, 0.25 
mM EDTA, pH 7.4) and concentrated 7-10 fold by volume using 30 kDa MWCO 
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concentrators (EMD Milipore). Mononucleosomes were immobilized onto beads largely as 
previously described [19]. Briefly, 4.66 pmol of the biotinylated adapter were bound to 200 
mg of paramagnetic streptavidin beads (NEB) at RT for 20 minutes in 1X binding buffer (10 
mM Tris-HCl, pH 7.4, 100 mM NaCl) to get a final reaction volume of 100 ml. The 
supernatant was removed and beads were washed three times with 50 ml of 1X ligation 
buffer (50 mM Tris, 10 mM MgCl2, 1 mM ATP, 10 mM DTT; pH 7.5). 6.99 pmol of WT, TA 
or TAc nucleosomes were added to the beads in 1X ligation buffer, in a final reaction volume 
of 100 ml. 800 U of T4 DNA ligase (NEB) were used to ligate the nucleosomes to the 
adapter. The reactions were carried out at RT for 5-6 hours. Excess unbound nucleosomes 
were then washed off. The beads were resuspended in 31 ml of 1X ligation buffer to get a 
final nucleosome concentration of 150 nM. The integrity of the assembled substrates was 
analyzed by digesting the beads with PstI at 37°C, for 5 hours. The liberated nucleosomes 
were analyzed on 4% native PAGE. 
 
Histone acetylation assay 
To compare the extent of acetylation of WT, TA and TAc nucleosomes, substrates were 
subjected to standard acetylation assays by ySAGA (Spt-Ada-Gcn5-acetyltransferase 
complex from Saccharomyces cerevisiae), under initial rate, sub-saturating nucleosome 
concentrations, as previously described [19]. Briefly, 1.5 nM ySAGA was used to acetylate 
10 nM of each kind of nucleosome in a 50 ml reaction volume of 1X HAT buffer (25 mM  
Tris-HCl, pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT, 1 mM PMSF, 10 mM sodium 
butyrate, 4.0 µM acetyl CoA with a specific activity of 5.78 Ci/mmol (Moravek 
Biochemicals)). The acetylation reaction was carried out at 30°C for 10 min. The beads were 
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washed 4 times at RT with 50 ml 1X wash buffer 1 (WB1- 100 mM NaCl, 50 mM Tris-HCl, 
10 mM MgCl2 , 1 mM DTT, 0.1% triton X-100) and for additional 5 times at 37°C with 15 
ml 1X WB2 (50 mM NH2OH , pH 7.5, 0.1% triton X-100), with 25 minutes incubation 
between each wash. The beads were then resuspended in 15 ml of 1X WB1 and added 
directly to 6 ml of scintillation cocktail. The samples were counted in Tri carb 4910 TR 
Liquid Scintillation Analyzer (Perkin Elmer). To account for non-H3 nucleosomal 
acetylation, the counts obtained from the WT and TAc nucleosomes were subtracted from 
those obtained from TA nucleosomes. The resultant extent of acetylation obtained from TAc 
substrate was compared to that of WT, which was normalized to 100%. 
 
Results 
We have been interested in how histone H3 tail acetylation is established by the SAGA 
family of transcriptional co-activitors [9, 19, 21], and how this acetylation affects chromatin 
structure and function, such as subsequent histone acetylation [21]. The SAGA complex from 
budding yeast has been shown to target four major residues on the H3 tail, with lysine 14 
being the most prominent acetylation site, followed by lysine 9, lysine 18, and then lysine 23 
(Figure 1) [22]. Nonsense suppression has been successfully employed to generate H3 
histones containing lysine 14 acetylation [11], and we sought to determine if such a strategy 
could be applied to generating histones containing as many as all four primary acetylations. 
Histone proteins can be recombinantly expressed in E. coli [16], and H3 K14 acetylated 
histone was previously generated from an overexpression plasmid containing an amber 
codon at amino acid residue 14 (Figure 1) [11]. Building off this sequence, we introduced 
additional putative acetyl-lysine residues by using site directed mutagenesis to convert lysine 
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codons to amber stop codons. Plasmids were constructed to contain up to four amber codons 
at the major sites of SAGA acetylation, where histones with intermediate levels of 
acetylation were made to match the known preference of lysine acetylation  - i.e. H3 histone 
containing one acetylation contained H3 K14 acetylation; K14 and K9 acetylation for two 
acetylations; and K14, K9, and K18 acetylation for three acetylation sites (Figure 1).  
 
 
 
Figure 1. Sequences of acetylated histone H3 proteins. Top row shows the sequence of the 
N-terminal tail of histone H3. Triangles point to the major sites of SAGA-mediated lysine 
acetylation. Subsequent rows show the acetylated histones generated, where ‘X’ denotes a 
site of amber codon replacement in the histone expression vector and acetyl-lysine residues 
in the expressed protein. The C-terminal portion of the histone sequence is not shown. The 
N-terminal portion of the histone reflects the sequence present after TEV cleavage of the 6-
His affinity tag: HHHHHHSQDPENLYFQG, with TEV cleavage between the last two 
residues, leaving the first H3 residue glycine. 
 
 To test the efficiency of acetyl-lysine incorporation, we first over-expressed singly 
acetylated H3 K14 acetylated histone according to literature protocols [11]. In this protocol, 
H3 protein expression is induced by IPTG addition in E. coli BL21 DE3 cells. However, for 
suppression of the amber stop codons, the cells also must contain a plasmid that 
constitutively expresses a tRNA containing an amber anticodon and a tRNA synthetase that 
can charge the tRNA with acetyl-lysine. Acetyl-lysine is added to the media, as well as NAD, 
which inhibits acetyl-lysine deacetylation. As expected, we observed visible amounts of H3 
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histone in whole cell extracts (data not shown). In the inclusion bodies, where overexpressed 
histones localize, the full-length histone was especially prevalent (Figure 2A). However, 
when the same conditions were used for overexpression of the tetra-acetylated H3 histone, no 
H3 histone was observed in the inclusion body (Figure 2A). Because full length expression 
of the tetra-acetylated histone requires efficient suppression of all four non-sense codon, and 
suppression involves a number of components, lack of expression could be due to a number 
of factors. During optimization, we found that increasing the concentration of acetyl-lysine in 
the cell media dramatically increased the amount of full-length histone expressed (Figure 
2B). Further, expression of histones with fewer than four acetyl-lysines was also feasible, 
with greater expression occurring when fewer amber codons are suppressed (Figure 2C). 
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Figure 2. Expression of acetylated histone H3 proteins. Proteins were resolved on an 18% 
SDS-PAGE gel and stained with Coomassie Blue. A) Comparison of amounts of full-length 
mono- and tetra-acetylated histone protein in inclusion bodies under published nonsense 
suppression conditions. B) Comparison of amounts of full-length tetra-acetylated histone 
protein in inclusion bodies with increasing concentrations of acetyl-lysine in the media. 1X 
represents previously utilized acetyl-lysine concentrations of 10 mM. C) Comparison of 
expression of full-length histone containing one to four acetyl-lysines in whole cell extracts 
using 40 mM acetyl-lysine concentrations. 
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 With improved tetra-acetylated H3 histone expression, we set out to purify the 
histone. Standard purification protocols for histones overexpressed in E. coli involve 
isolating inclusion bodies and then further purifying denatured histone by size exclusion and 
cation exchange chromatography. With these steps, we were able to increase the purity of the 
H3 histone, but not enough to obtain pure protein (data not shown). In the literature protocol 
for the singly acetylated histone [11], a TEV-cleavable, six-His affinity tag was fused to the 
N-terminus to facilitate purification, and a similar tag was investigated for the multiply 
acetylated histones. For the tagged, tetra-acetylated histone, induction and inclusion body 
purification proceeded to enrich the amount of full-length H3 histone (Figure 3A, lanes 1-3). 
Histone could then be unfolded and captured on nickel-NTA beads under denaturing 
conditions to further enrich purity (Figure 3A, lane 4). After solvent exchange into a non-
denaturing buffer compatible with TEV protease, H3 histone was liberated from the nickel 
beads (Figure 3A, lane 5). We found that to get complete cleavage required optimization of 
the both the binding and cleavage steps. For histone binding, we utilized just enough nickel-
NTA beads to get complete histone binding, because additional beads decreased cleavage 
efficiency. Because commercially available TEV protease is also His-tagged, we believed 
that the nickel-NTA beads could be sequestering away TEV protease. Consistent with this 
idea, we found that addition of up to 50 mM imidazole improved the cleavage efficiency of 
the immobilized histone (higher concentrations of imidazole resulted in elution of uncleaved 
histone). The amount of TEV protease was also optimized to minimize the amount of 
protease required to give complete cleavage of the tetra-acetylated histone. Despite full 
cleavage, the histone could only be eluted from the beads under denaturing conditions, where 
a significant amount of contaminating proteins coelute. A cation exchange chromatography 
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step under denaturing conditions resulted in histone protein sufficiently pure for subsequent 
applications. (Figure 3A, lane 6). Because we were working with relatively small amounts of 
protein, we found that reversed phase C8 Sep-Pak purification was an efficient way to 
concentrate and desalt the purified tetra-acetylated histone after cation exchange 
chromatography. 
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Figure 3. A) Analysis of tetra-acetylated H3 histone purity at various steps of the modified 
purification protocol. Proteins were resolved on an 18% SDS-PAGE gel and stained with 
Coomassie Blue. Pre- and post-induction of whole cell extracts are shown in lanes 1 and 2, 
respectively. Lane 3 shows protein composition following inclusion body purification. Lanes 
4 and 5 show proteins bound to nickel-NTA-bead and then released by TEV protease, 
respectively. Lane 6 shows the protein composition following cation exchange 
chromatography. C) MALDI-TOF mass spectrometry analysis of purified tetra-acetylated H3 
protein. 
 
 While the purification step generated full-length H3 histone, additional 
characterization was necessary to confirm the acetylation state of the histone. Full-length H3 
protein lacking tetra-acetylation could result from amber suppression by non-acetyl-lysine 
codons, or by enzymatic deacetylation of the acetyl-lysine residues. To rule out these 
possibilities, the mass of the purified histone was determined by MALDI mass spectrometry 
(Figure 3B), and this analysis confirmed that the isolated protein was tetra-acetylated (15,425 
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Da expected, 15,428 Da observed, 42 Da per acetyl group). The ultimate yield of the tetra-
acetylated H3 histone was 0.06 mg/g of cells. While this is significantly less than the 0.82 – 
2.45 mg/g of cells that is typically obtainable for unacetylated H3, it is not significantly 
worse than the 0.17 mg/g of cells that was obtained from original single-site nonsense 
suppression studies [11]. A similar purification protocol was applied to each of the other 
acetylated histones, and yielded 2.45 mg/g of cells, 0.65 mg/g of cells, and 0.24 mg/g of cells 
for H3 histones containing one, two and three acetylated lysines, respectively. 
 The purity and amount of tetra-acetylated H3 was sufficient to incorporate into a 
histone octamer and then a mononucleosome. To generate histone octamer, the tetra-
acetylated H3 was combined with recombinant H2A, H2B, and H4 histones under denaturing 
conditions and dialyzed into a high salt (2M NaCl) solution [16]. Histone octamer was 
resolved from incomplete assembly products by size exclusion chromatography, and eluted 
identically to wild-type octamers. Denaturing protein gel electrophoresis of the wild type, 
tetra-acetylated H3, and tetra-alanine H3 octamers look similar (Figure 4A), with some 
changes in electrophoretic mobility of acetylated and alanine-containing H3 histone relative 
to the wild-type H3.  Equal amounts of octamers were then incorporated into 
mononucleosomes by deposition onto a 177 base pair 601 double stranded DNA template by 
rapid dilution [20], and all three mononucleosomes appear largely similar in their extent of 
assembly and their electrophoretic mobility (Figure 4B). Each mononucleosome was 
immobilized onto a paramagnetic bead, and then used as a substrate for a SAGA-mediated 
acetyltransferase assay (Figure 4C). As expected, the nucleosome containing acetyl-lysine at 
the major SAGA acetylation sites showed a significant reduction of new acetylation relative 
to a nucleosome that was not pre-acetylated. The reduction in the amount of acetylation was 
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similar to that observed for a nucleosome in which the four major H3 tail acetylation sites 
were mutated to alanine, indicating that the tetra-acetylated histone prevents SAGA-mediated 
histone acetylation in a manner similar to loss of the lysine residue.  
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Figure 4. Utilization of tetra-acetylated histone H3 protein. A) Denaturing protein gel 
analysis of histone octamers containing unacetylated, tetra-alanine, or tetra-acetylated H3 
histones. Histones were resolved on an 18% SDS PAGE gel with Coomassie Blue staining. 
B) Native gel analysis of mononucleosomes containing tetra-alanine, tetra-acetylated, or 
unacetylated H3 histone. Species were resolved on a 4% native PAGE gel with ethidium 
bromide staining. C) Comparative extent of SAGA-mediated mononucleosome acetylation 
relative to mononucleosomes in which the major H3 tail acetylation sites were mutated to 
alanine. To determine the extent of acetylation, the amount of radioactive acetyl 
incorporation was subtracted from that of the tetra-alanine mononucleosome and then 
normalized to the wild-type mononucleosome. Data represents four independent trials. 
 
 
 
Discussion 
We have shown that nonsense suppression can be used to incorporate multiple acetyl-lysine 
residues into the tail of H3 histone protein. One major hurdle we encountered was expressing 
full-length protein. This difficulty presumably arises because full-length expression requires 
efficient nonsense suppression at every amber codon. Consistent with this idea, we observed 
that the amount of full-length protein decreases with increasing numbers of amber mutations 
  
115 
to suppress (Figure 2C). Thus, conditions to optimize nonsense suppression were necessary. 
We found that increasing the amount of acetyl-lysine present in the media increases full-
length protein expression (Figure 2B), suggesting that a key difficulty in nonsense 
suppression in this system is charging the nonsense suppression tRNA with acetyl-lysine. It 
is likely that acetyl-lysine is limiting in the cell and by increasing its concentration in the 
media, intracellular concentrations increase to drive the action of the synthetase. For our 
purposes, a four-fold increase in acetyl-lysine concentrations was sufficient for generating 
amounts of tetra-acetylated histone we needed. However, for the increasing acetyl-lysine 
concentrations used (Figure 2B), we did not observe saturation of histone expression, 
suggesting that even greater levels of expression should be possible. In this case, the only 
trade-off may ultimately be the cost of acetyl-lysine. Further, because nonsense suppression 
is a complicated process, other steps in the reaction might also benefit from optimization. 
This could include improving the expression levels and properties of the tRNA and 
synthetase, as well as optimizing the length and timing of histone induction relative to acetyl-
lysine addition.  
 The other major hurdle encountered was in the purification of the multiply acetylated 
histones. Inclusion body preparations, nickel-NTA beads binding, and cation exchange 
chromatography were highly efficient, while proteolytic cleavage of the histone from the 
nickel-NTA required significant optimization in the bead, imidazole, and TEV protease 
amounts. Even under these optimized conditions, a significant amount of TEV protease was 
required. The inefficiency of TEV cleavage could be due in part to sequestration of the 
protease to the nickel-NTA beads, and alternative forms of TEV-protease that do not contain 
a His-tag might improve cleavage efficiency. Another potential contributor could be the 
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inability of H3 histone to form a well-behaved globular structure under native conditions. In 
such a case, it is likely that affinity captured histones form aggregates on the surface of the 
nickel-NTA beads when solvent is exchanged for proteolysis, making the cleavage site less 
accessible. A cleavage strategy that can be performed under denaturing conditions would 
likely avoid this issue. 
 In our studies, we focus on incorporating multiple acetyl-lysine residues into the H3 
histone at known sites of SAGA-mediated acetylation. However, we feel our strategies 
should be applicable to other sites within the H3 histone, to other acetylation sites in other 
histones, and even to acetylation of other proteins. Within the H3 histone, Chin and 
coworkers have previously shown that many different sites within the H3 histone can be 
individually acetylated, suggesting that, in general, nonsense suppression is not highly 
sequence dependent in the H3 histone. This idea is further supported by the fact that we 
observe a similar degree in decrease in histone expression with every amber codon added. 
Thus, we expect that other combination of multiple lysine acetylations in H3 histone should 
be possible. With respect to other histones, multiple acetylations may also be possible. For 
example, while the H4 histone had proven recalcitrant to single site acetyl-lysine nonsense 
suppression, recent studies have shown that with codon optimization, H4 K16 acetylated 
histones can be generated at level comparable to those found for single sites acetylation H3 
histones in the original Chin study. Our improvements in H3 expression and purification may 
be directly applicable to H4 histones, as well as others. Finally, for non-histone proteins, 
especially those that can be purified more effectively than histone, increasing acetyl-lysine 
concentrations might prove sufficient to allow for improved incorporation of single or 
multiple acetyl-lysine residues. 
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Conclusion 
We have shown that we can extend a nonsense suppression strategy for incorporating acetyl-
lysine into H3 histones to generate histones containing up to four acetyl-lysine residues. Key 
to achieving this is improved histone expression via an increase in the amount of acetyl-
lysine added to the cell media, and a combined affinity capture and ion exchange 
chromatography purification strategy. The tetra-acetylated H3 histone is generated in 
sufficient yield and purity to be incorporated into histone octamers and nucleosomes, and we 
expect that the insight gained from our study could aid in utilizing nonsense suppression to 
incorporate acetyl-lysine residues into other histones and non-histone proteins. 
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